data_2l93_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l93 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.198 0.523 . . . . 1.0 112.329 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.262 0.468 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 111.443 0.164 . . . . 1.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 112.104 0.409 . . . . 1.0 112.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.258 0.836 . . . . 1.0 113.258 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 120.918 0.39 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 120.569 0.223 . . . . 1.0 111.536 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.225 0.535 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.81 -0.138 . . . . 1.0 110.921 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.784 0.29 . . . . 1.0 111.784 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.46 169.12 20.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.332 1.453 . . . . 1.0 112.269 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -142.56 58.49 7.39 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.253 1.421 . . . . 1.0 113.865 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.62 36.48 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.15 3.9 . . . . 1.0 114.335 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 52.11 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 127.082 2.153 . . . . 1.0 114.428 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -134.59 -72.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.86 140.96 15.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.118 0.967 . . . . 1.0 111.07 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 tp -141.55 27.28 1.89 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.83 1.252 . . . . 1.0 112.519 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.255 1.393 0 C-N-CA 125.825 1.65 . . . . 1.0 113.489 176.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 111.516 0.191 . . . . 1.0 111.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.27 23.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.305 1.442 . . . . 1.0 112.182 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -147.94 138.87 13.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 125.5 1.52 . . . . 1.0 111.061 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 175.59 10.46 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.602 2.868 . . . . 1.0 112.327 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.82 157.57 43.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.216 1.006 . . . . 1.0 112.738 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -87.28 -7.1 58.21 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.93 21.53 2.84 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 1.0 112.945 -173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -138.02 160.23 39.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.765 1.626 . . . . 1.0 111.458 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.269 1.827 . . . . 1.0 112.291 -178.743 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.7 167.53 24.4 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.454 1.501 . . . . 1.0 112.106 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.06 154.09 93.26 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.802 0.841 . . . . 1.0 111.347 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.62 153.88 64.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.998 2.466 . . . . 1.0 111.895 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.82 152.47 45.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.445 -0.785 . . . . 1.0 112.329 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -62.13 -42.84 99.63 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -143.79 21.94 1.79 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.8 mt -122.5 21.03 10.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.505 1.522 . . . . 1.0 112.88 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.742 2.017 . . . . 1.0 112.095 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.598 0.221 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.18 167.22 25.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.235 1.414 . . . . 1.0 112.296 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.66 66.64 18.36 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.491 1.516 . . . . 1.0 111.293 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.32 161.82 43.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.393 2.729 . . . . 1.0 112.891 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.89 171.52 16.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.281 1.432 . . . . 1.0 112.262 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -133.03 -84.03 0.47 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.78 144.75 15.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.873 1.269 . . . . 1.0 111.456 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.82 143.01 46.11 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.88 1.272 . . . . 1.0 111.777 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.112 1.765 . . . . 1.0 112.305 177.037 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.76 168.26 23.4 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.266 1.427 . . . . 1.0 112.138 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -66.06 158.21 77.33 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.514 1.126 . . . . 1.0 112.134 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -53.07 149.81 26.09 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.662 2.908 . . . . 1.0 114.276 170.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.98 163.19 28.3 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -68.67 -30.03 68.62 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 7.18 10.13 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.2 mt -132.16 25.38 4.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.13 1.372 . . . . 1.0 113.022 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.639 1.975 . . . . 1.0 112.305 175.47 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.497 0.189 . . . . 1.0 111.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.13 -21.56 58.76 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.792 1.404 . . . . 1.0 114.792 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -135.78 65.85 61.23 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.882 1.673 . . . . 1.0 111.76 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -68.04 163.26 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.456 2.771 . . . . 1.0 112.956 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.88 166.88 6.74 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.234 1.014 . . . . 1.0 113.605 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -131.81 -76.38 0.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.86 141.74 14.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.556 1.142 . . . . 1.0 110.975 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.77 27.17 1.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.257 1.023 . . . . 1.0 112.942 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.391 1.876 . . . . 1.0 112.624 -176.344 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 111.678 0.251 . . . . 1.0 111.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.2 23.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.375 1.47 . . . . 1.0 112.147 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.91 73.73 16.56 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.3 1.44 . . . . 1.0 112.756 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.79 155.56 10.57 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.673 2.915 . . . . 1.0 114.275 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 152.51 40.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.616 -0.678 . . . . 1.0 112.609 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -134.96 18.66 3.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.49 49.49 1.41 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.387 1.075 . . . . 1.0 111.402 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.76 17.15 8.06 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.917 1.287 . . . . 1.0 113.278 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.841 1.656 . . . . 1.0 113.391 177.409 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.578 0.227 . . . . 1.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.73 167.89 24.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.317 1.447 . . . . 1.0 112.123 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -135.57 63.4 53.72 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.879 1.671 . . . . 1.0 111.605 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.77 157.85 59.13 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.333 2.689 . . . . 1.0 112.689 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.1 171.81 17.86 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.037 1.335 . . . . 1.0 112.46 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.97 -82.11 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.52 143.36 16.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.052 1.741 . . . . 1.0 109.264 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.1 tp -78.55 38.27 0.31 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.58 1.152 . . . . 1.0 113.204 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 125.986 1.714 . . . . 1.0 114.249 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.15 17.74 2.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.567 1.147 . . . . 1.0 114.094 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -143.42 81.91 11.98 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.362 1.465 . . . . 1.0 111.441 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.43 160.68 4.73 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.28 3.32 . . . . 1.0 115.249 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.99 173.99 12.76 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.868 1.667 . . . . 1.0 111.443 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -51.66 40.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.75 133.17 7.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.683 1.193 . . . . 1.0 111.01 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -138.13 21.66 2.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.385 1.474 . . . . 1.0 112.579 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.205 1.402 . . . . 1.0 113.85 178.051 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.828 0.307 . . . . 1.0 111.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.49 18.78 3.34 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.902 1.281 . . . . 1.0 113.776 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -52.73 -35.67 26.94 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 115.961 1.838 . . . . 1.0 115.961 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -65.58 36.97 0.12 Allowed 'Trans proline' 0 CA--C 1.551 1.354 1 C-N-CA 125.873 4.382 . . . . 1.0 116.27 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.0 152.34 28.15 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.755 -1.215 . . . . 1.0 114.028 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -95.56 -29.47 14.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.28 33.04 3.89 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.247 1.019 . . . . 1.0 113.263 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.54 -17.42 64.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.853 2.061 . . . . 1.0 112.376 -178.625 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.675 0.25 . . . . 1.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.5 169.06 21.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.341 1.456 . . . . 1.0 112.173 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -135.34 150.15 71.7 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 125.841 1.656 . . . . 1.0 111.103 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.59 35.67 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.754 3.636 . . . . 1.0 113.488 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.98 176.57 10.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.1 1.76 . . . . 1.0 111.878 -169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -135.95 28.18 3.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -139.7 19.6 2.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.979 0.912 . . . . 1.0 112.873 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.68 22.93 7.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.227 1.411 . . . . 1.0 112.998 -169.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.796 2.038 . . . . 1.0 112.112 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.697 0.258 . . . . 1.0 111.697 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.17 19.44 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.5 1.12 . . . . 1.0 113.794 -174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.42 150.18 90.26 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.318 1.047 . . . . 1.0 112.176 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 164.79 34.54 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.38 2.72 . . . . 1.0 112.721 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.72 171.66 16.34 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.499 1.52 . . . . 1.0 112.104 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -143.52 -73.02 0.28 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -144.92 151.94 39.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.532 1.133 . . . . 1.0 112.526 -171.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.4 171.66 15.67 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.972 1.709 . . . . 1.0 111.01 -176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.277 1.831 . . . . 1.0 111.716 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.03 159.76 41.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.695 1.198 . . . . 1.0 112.399 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -62.36 -46.77 90.23 Favored Pre-proline 0 N--CA 1.478 0.942 0 N-CA-C 117.331 2.345 . . . . 1.0 117.331 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.43 148.25 37.82 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.699 2.266 . . . . 1.0 113.379 -169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.63 164.53 25.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.272 1.029 . . . . 1.0 113.258 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.37 -35.92 82.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.44 23.12 2.34 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.1 0.96 . . . . 1.0 112.593 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.69 154.22 47.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.927 1.691 . . . . 1.0 111.177 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.394 1.878 . . . . 1.0 112.368 -177.332 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.649 0.24 . . . . 1.0 111.649 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.03 169.92 19.53 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.407 1.483 . . . . 1.0 112.031 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.77 152.46 72.52 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 126.292 1.837 . . . . 1.0 111.191 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.87 158.76 49.55 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.303 2.669 . . . . 1.0 113.031 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.65 32.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.01 1.724 . . . . 1.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.21 -49.97 62.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.56 139.22 8.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.172 1.389 . . . . 1.0 111.105 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.97 163.55 32.49 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.719 1.608 . . . . 1.0 110.872 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.217 1.807 . . . . 1.0 113.713 179.318 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.268 0.099 . . . . 1.0 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.62 160.78 40.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.456 1.102 . . . . 1.0 112.823 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -61.6 -43.29 87.97 Favored Pre-proline 0 N--CA 1.481 1.086 0 N-CA-C 117.1 2.259 . . . . 1.0 117.1 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -84.18 35.39 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.985 3.123 . . . . 1.0 113.957 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.99 171.11 17.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.779 1.632 . . . . 1.0 112.146 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -138.02 -75.05 0.4 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -148.37 159.0 44.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.775 1.23 . . . . 1.0 113.864 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.62 24.04 9.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.944 1.298 . . . . 1.0 112.85 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.251 1.421 . . . . 1.0 112.383 169.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.897 0.332 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.3 165.72 13.5 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.492 1.117 . . . . 1.0 113.448 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -144.61 157.0 56.27 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.522 1.529 . . . . 1.0 112.031 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.69 56.53 5.97 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.632 3.555 . . . . 1.0 113.579 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.85 20.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.892 1.277 . . . . 1.0 112.44 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -136.13 -76.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -143.44 163.92 31.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.464 1.106 . . . . 1.0 112.609 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -128.22 159.55 34.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.505 1.522 . . . . 1.0 111.658 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.256 1.822 . . . . 1.0 112.691 -173.15 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.537 0.199 . . . . 1.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.0 168.02 24.23 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.414 1.486 . . . . 1.0 112.147 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -138.82 153.0 71.62 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 125.924 1.69 . . . . 1.0 111.297 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.34 164.16 36.66 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.155 2.57 . . . . 1.0 112.927 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.02 172.17 18.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.797 1.639 . . . . 1.0 111.536 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.35 -51.49 51.68 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -160.69 144.49 13.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.156 1.382 . . . . 1.0 110.619 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 67.9 mt -144.54 157.58 44.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.379 1.472 . . . . 1.0 111.252 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.344 1.857 . . . . 1.0 112.466 -179.147 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.64 0.257 . . . . 1.0 111.574 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.95 164.75 32.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.277 1.431 . . . . 1.0 112.107 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.5 mtp85 -132.06 -36.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 116.836 2.162 . . . . 1.0 116.836 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.44 157.52 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.949 3.099 . . . . 1.0 114.599 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 161.62 19.85 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -130.03 18.52 5.53 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -142.63 16.32 1.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -129.79 23.87 5.37 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.85 1.26 . . . . 1.0 112.957 -169.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.928 1.691 . . . . 1.0 113.656 174.744 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.874 0.324 . . . . 1.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.93 28.3 8.38 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 116.587 2.069 . . . . 1.0 116.587 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -136.99 62.32 39.19 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.946 1.698 . . . . 1.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.97 163.46 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.649 2.899 . . . . 1.0 113.288 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.92 15.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.575 1.55 . . . . 1.0 112.049 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -137.43 -55.36 0.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -164.9 140.66 5.58 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.806 1.185 . . . . 1.0 111.914 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 16.93 2.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.507 1.299 . . . . 1.0 114.507 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.26 1.824 . . . . 1.0 111.967 -178.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.761 0.282 . . . . 1.0 111.761 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.63 169.47 19.57 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.214 1.406 . . . . 1.0 112.131 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.55 149.65 94.99 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.504 1.122 . . . . 1.0 112.752 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -83.83 31.86 0.51 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 124.923 3.749 . . . . 1.0 113.431 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.53 170.59 21.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.735 2.014 . . . . 1.0 110.921 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -92.29 -22.93 19.47 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.22 13.78 8.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.093 0.957 . . . . 1.0 113.499 -170.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.94 160.92 37.46 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.688 1.595 . . . . 1.0 111.693 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.112 1.765 . . . . 1.0 112.2 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.198 0.523 . . . . 1.0 112.329 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.262 0.468 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 111.443 0.164 . . . . 1.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 112.104 0.409 . . . . 1.0 112.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 130' ' ' LEU . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.258 0.836 . . . . 1.0 113.258 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 120.918 0.39 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 120.569 0.223 . . . . 1.0 111.536 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.225 0.535 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.81 -0.138 . . . . 1.0 110.921 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.784 0.29 . . . . 1.0 111.784 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.46 169.12 20.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.332 1.453 . . . . 1.0 112.269 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -142.56 58.49 7.39 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.253 1.421 . . . . 1.0 113.865 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.62 36.48 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.15 3.9 . . . . 1.0 114.335 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 52.11 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 127.082 2.153 . . . . 1.0 114.428 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -134.59 -72.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.86 140.96 15.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.118 0.967 . . . . 1.0 111.07 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 tp -141.55 27.28 1.89 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.83 1.252 . . . . 1.0 112.519 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.255 1.393 0 C-N-CA 125.825 1.65 . . . . 1.0 113.489 176.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 111.516 0.191 . . . . 1.0 111.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.27 23.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.305 1.442 . . . . 1.0 112.182 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -147.94 138.87 13.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 125.5 1.52 . . . . 1.0 111.061 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 175.59 10.46 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.602 2.868 . . . . 1.0 112.327 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.82 157.57 43.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.216 1.006 . . . . 1.0 112.738 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -87.28 -7.1 58.21 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.93 21.53 2.84 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 1.0 112.945 -173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -138.02 160.23 39.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.765 1.626 . . . . 1.0 111.458 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.269 1.827 . . . . 1.0 112.291 -178.743 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.7 167.53 24.4 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.454 1.501 . . . . 1.0 112.106 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.06 154.09 93.26 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.802 0.841 . . . . 1.0 111.347 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.62 153.88 64.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.998 2.466 . . . . 1.0 111.895 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.82 152.47 45.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.445 -0.785 . . . . 1.0 112.329 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -62.13 -42.84 99.63 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -143.79 21.94 1.79 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.8 mt -122.5 21.03 10.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.505 1.522 . . . . 1.0 112.88 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.742 2.017 . . . . 1.0 112.095 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.598 0.221 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.18 167.22 25.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.235 1.414 . . . . 1.0 112.296 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.66 66.64 18.36 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.491 1.516 . . . . 1.0 111.293 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.32 161.82 43.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.393 2.729 . . . . 1.0 112.891 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.89 171.52 16.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.281 1.432 . . . . 1.0 112.262 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -133.03 -84.03 0.47 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.78 144.75 15.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.873 1.269 . . . . 1.0 111.456 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.82 143.01 46.11 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.88 1.272 . . . . 1.0 111.777 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.112 1.765 . . . . 1.0 112.305 177.037 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.76 168.26 23.4 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.266 1.427 . . . . 1.0 112.138 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -66.06 158.21 77.33 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.514 1.126 . . . . 1.0 112.134 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -53.07 149.81 26.09 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.662 2.908 . . . . 1.0 114.276 170.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.98 163.19 28.3 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -68.67 -30.03 68.62 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 7.18 10.13 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.2 mt -132.16 25.38 4.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.13 1.372 . . . . 1.0 113.022 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.639 1.975 . . . . 1.0 112.305 175.47 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.497 0.189 . . . . 1.0 111.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.13 -21.56 58.76 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.792 1.404 . . . . 1.0 114.792 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -135.78 65.85 61.23 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.882 1.673 . . . . 1.0 111.76 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -68.04 163.26 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.456 2.771 . . . . 1.0 112.956 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.88 166.88 6.74 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.234 1.014 . . . . 1.0 113.605 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -131.81 -76.38 0.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.86 141.74 14.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.556 1.142 . . . . 1.0 110.975 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.77 27.17 1.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.257 1.023 . . . . 1.0 112.942 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.391 1.876 . . . . 1.0 112.624 -176.344 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 111.678 0.251 . . . . 1.0 111.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.2 23.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.375 1.47 . . . . 1.0 112.147 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.91 73.73 16.56 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.3 1.44 . . . . 1.0 112.756 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.79 155.56 10.57 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.673 2.915 . . . . 1.0 114.275 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 152.51 40.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.616 -0.678 . . . . 1.0 112.609 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -134.96 18.66 3.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.49 49.49 1.41 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.387 1.075 . . . . 1.0 111.402 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.76 17.15 8.06 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.917 1.287 . . . . 1.0 113.278 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.841 1.656 . . . . 1.0 113.391 177.409 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.578 0.227 . . . . 1.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.73 167.89 24.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.317 1.447 . . . . 1.0 112.123 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -135.57 63.4 53.72 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.879 1.671 . . . . 1.0 111.605 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.77 157.85 59.13 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.333 2.689 . . . . 1.0 112.689 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.1 171.81 17.86 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.037 1.335 . . . . 1.0 112.46 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.97 -82.11 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.52 143.36 16.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.052 1.741 . . . . 1.0 109.264 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.1 tp -78.55 38.27 0.31 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.58 1.152 . . . . 1.0 113.204 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 125.986 1.714 . . . . 1.0 114.249 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.15 17.74 2.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.567 1.147 . . . . 1.0 114.094 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -143.42 81.91 11.98 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.362 1.465 . . . . 1.0 111.441 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.43 160.68 4.73 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.28 3.32 . . . . 1.0 115.249 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.99 173.99 12.76 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.868 1.667 . . . . 1.0 111.443 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -51.66 40.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.75 133.17 7.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.683 1.193 . . . . 1.0 111.01 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -138.13 21.66 2.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.385 1.474 . . . . 1.0 112.579 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.205 1.402 . . . . 1.0 113.85 178.051 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.828 0.307 . . . . 1.0 111.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.49 18.78 3.34 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.902 1.281 . . . . 1.0 113.776 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -52.73 -35.67 26.94 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 115.961 1.838 . . . . 1.0 115.961 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -65.58 36.97 0.12 Allowed 'Trans proline' 0 CA--C 1.551 1.354 1 C-N-CA 125.873 4.382 . . . . 1.0 116.27 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.0 152.34 28.15 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.755 -1.215 . . . . 1.0 114.028 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -95.56 -29.47 14.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.28 33.04 3.89 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.247 1.019 . . . . 1.0 113.263 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.54 -17.42 64.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.853 2.061 . . . . 1.0 112.376 -178.625 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.675 0.25 . . . . 1.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.5 169.06 21.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.341 1.456 . . . . 1.0 112.173 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -135.34 150.15 71.7 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 125.841 1.656 . . . . 1.0 111.103 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.59 35.67 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.754 3.636 . . . . 1.0 113.488 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.98 176.57 10.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.1 1.76 . . . . 1.0 111.878 -169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -135.95 28.18 3.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -139.7 19.6 2.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.979 0.912 . . . . 1.0 112.873 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.68 22.93 7.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.227 1.411 . . . . 1.0 112.998 -169.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.796 2.038 . . . . 1.0 112.112 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.697 0.258 . . . . 1.0 111.697 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.17 19.44 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.5 1.12 . . . . 1.0 113.794 -174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.42 150.18 90.26 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.318 1.047 . . . . 1.0 112.176 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 164.79 34.54 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.38 2.72 . . . . 1.0 112.721 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.72 171.66 16.34 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.499 1.52 . . . . 1.0 112.104 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 130' ' ' LEU . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -143.52 -73.02 0.28 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -144.92 151.94 39.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.532 1.133 . . . . 1.0 112.526 -171.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.4 171.66 15.67 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.972 1.709 . . . . 1.0 111.01 -176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.277 1.831 . . . . 1.0 111.716 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.03 159.76 41.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.695 1.198 . . . . 1.0 112.399 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -62.36 -46.77 90.23 Favored Pre-proline 0 N--CA 1.478 0.942 0 N-CA-C 117.331 2.345 . . . . 1.0 117.331 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.43 148.25 37.82 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.699 2.266 . . . . 1.0 113.379 -169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.63 164.53 25.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.272 1.029 . . . . 1.0 113.258 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.37 -35.92 82.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.44 23.12 2.34 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.1 0.96 . . . . 1.0 112.593 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.69 154.22 47.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.927 1.691 . . . . 1.0 111.177 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.394 1.878 . . . . 1.0 112.368 -177.332 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.649 0.24 . . . . 1.0 111.649 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.03 169.92 19.53 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.407 1.483 . . . . 1.0 112.031 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.77 152.46 72.52 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 126.292 1.837 . . . . 1.0 111.191 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.87 158.76 49.55 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.303 2.669 . . . . 1.0 113.031 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.65 32.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.01 1.724 . . . . 1.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.21 -49.97 62.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.56 139.22 8.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.172 1.389 . . . . 1.0 111.105 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.97 163.55 32.49 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.719 1.608 . . . . 1.0 110.872 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.217 1.807 . . . . 1.0 113.713 179.318 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.268 0.099 . . . . 1.0 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.62 160.78 40.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.456 1.102 . . . . 1.0 112.823 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -61.6 -43.29 87.97 Favored Pre-proline 0 N--CA 1.481 1.086 0 N-CA-C 117.1 2.259 . . . . 1.0 117.1 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -84.18 35.39 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.985 3.123 . . . . 1.0 113.957 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.99 171.11 17.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.779 1.632 . . . . 1.0 112.146 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -138.02 -75.05 0.4 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -148.37 159.0 44.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.775 1.23 . . . . 1.0 113.864 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.62 24.04 9.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.944 1.298 . . . . 1.0 112.85 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.251 1.421 . . . . 1.0 112.383 169.771 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.897 0.332 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.3 165.72 13.5 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.492 1.117 . . . . 1.0 113.448 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -144.61 157.0 56.27 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.522 1.529 . . . . 1.0 112.031 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.69 56.53 5.97 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.632 3.555 . . . . 1.0 113.579 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.85 20.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.892 1.277 . . . . 1.0 112.44 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -136.13 -76.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -143.44 163.92 31.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.464 1.106 . . . . 1.0 112.609 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -128.22 159.55 34.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.505 1.522 . . . . 1.0 111.658 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.256 1.822 . . . . 1.0 112.691 -173.15 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.537 0.199 . . . . 1.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.0 168.02 24.23 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.414 1.486 . . . . 1.0 112.147 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -138.82 153.0 71.62 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 125.924 1.69 . . . . 1.0 111.297 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.34 164.16 36.66 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.155 2.57 . . . . 1.0 112.927 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.02 172.17 18.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.797 1.639 . . . . 1.0 111.536 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.35 -51.49 51.68 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -160.69 144.49 13.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.156 1.382 . . . . 1.0 110.619 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 67.9 mt -144.54 157.58 44.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.379 1.472 . . . . 1.0 111.252 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.344 1.857 . . . . 1.0 112.466 -179.147 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.64 0.257 . . . . 1.0 111.574 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.95 164.75 32.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.277 1.431 . . . . 1.0 112.107 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 79.5 mtp85 -132.06 -36.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 116.836 2.162 . . . . 1.0 116.836 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.478 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 72.5 Cg_exo -56.44 157.52 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.949 3.099 . . . . 1.0 114.599 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 161.62 19.85 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -130.03 18.52 5.53 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -142.63 16.32 1.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -129.79 23.87 5.37 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.85 1.26 . . . . 1.0 112.957 -169.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.928 1.691 . . . . 1.0 113.656 174.744 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.874 0.324 . . . . 1.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.93 28.3 8.38 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 116.587 2.069 . . . . 1.0 116.587 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -136.99 62.32 39.19 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.946 1.698 . . . . 1.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.97 163.46 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.649 2.899 . . . . 1.0 113.288 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.92 15.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.575 1.55 . . . . 1.0 112.049 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -137.43 -55.36 0.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -164.9 140.66 5.58 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.806 1.185 . . . . 1.0 111.914 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 16.93 2.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.507 1.299 . . . . 1.0 114.507 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.26 1.824 . . . . 1.0 111.967 -178.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.761 0.282 . . . . 1.0 111.761 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.63 169.47 19.57 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.214 1.406 . . . . 1.0 112.131 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.55 149.65 94.99 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.504 1.122 . . . . 1.0 112.752 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -83.83 31.86 0.51 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 124.923 3.749 . . . . 1.0 113.431 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.53 170.59 21.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.735 2.014 . . . . 1.0 110.921 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -92.29 -22.93 19.47 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.22 13.78 8.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.093 0.957 . . . . 1.0 113.499 -170.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.94 160.92 37.46 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.688 1.595 . . . . 1.0 111.693 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.112 1.765 . . . . 1.0 112.2 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.152 0 N-CA-C 114.428 1.27 . . . . 1.0 114.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 121.198 0.523 . . . . 1.0 112.329 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 112.262 0.468 . . . . 1.0 112.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm . . . . . 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 111.443 0.164 . . . . 1.0 111.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.028 1.121 . . . . 1.0 114.028 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 111.878 0.325 . . . . 1.0 111.878 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 112.104 0.409 . . . . 1.0 112.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 130' ' ' LEU . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.258 0.836 . . . . 1.0 113.258 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.802 0 CA-C-O 120.918 0.39 . . . . 1.0 111.226 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 112.44 0.533 . . . . 1.0 112.44 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 CA-C-O 120.569 0.223 . . . . 1.0 111.536 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 121.225 0.535 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 119.81 -0.138 . . . . 1.0 110.921 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.784 0.29 . . . . 1.0 111.784 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.46 169.12 20.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.332 1.453 . . . . 1.0 112.269 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -142.56 58.49 7.39 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.253 1.421 . . . . 1.0 113.865 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -76.62 36.48 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.15 3.9 . . . . 1.0 114.335 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 52.11 -170.21 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 127.082 2.153 . . . . 1.0 114.428 -170.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -134.93 -31.1 1.03 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.624 1.569 . . . . 1.0 113.158 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.48 157.73 46.16 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.689 1.196 . . . . 1.0 111.337 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 30.7 t -143.02 142.73 31.66 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.209 1.804 . . . . 1.0 110.629 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -142.3 172.4 12.74 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.647 1.179 . . . . 1.0 113.28 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.17 173.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.918 2.087 . . . . 1.0 113.072 -169.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -138.54 -47.84 0.51 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.572 0.749 . . . . 1.0 112.65 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -151.1 -60.25 0.18 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.87 0.759 . . . . 1.0 112.866 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -78.22 -18.19 55.76 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.035 1.494 . . . . 1.0 115.035 -170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.77 -164.58 32.25 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.867 1.222 . . . . 1.0 112.132 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.41 125.85 15.52 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.292 0.637 . . . . 1.0 110.948 170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.8 t -117.57 -41.59 2.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.88 0.872 . . . . 1.0 113.205 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -151.22 163.32 39.14 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.063 1.345 . . . . 1.0 111.788 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.7 p -132.08 163.37 28.61 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.669 1.588 . . . . 1.0 112.301 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -149.44 158.26 44.01 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.578 1.151 . . . . 1.0 112.061 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.6 p -109.28 -14.95 14.38 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.08 1.752 . . . . 1.0 113.694 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.01 63.18 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.009 1.29 . . . . 1.0 113.637 -169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -76.64 140.71 41.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.54 1.136 . . . . 1.0 111.704 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.3 -164.93 52.07 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 123.871 0.748 . . . . 1.0 114.567 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -58.31 132.64 54.23 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.304 1.441 . . . . 1.0 111.972 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 m -56.82 129.31 77.55 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.647 1.179 . . . . 1.0 111.723 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.6 146.11 66.4 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.6 2.867 . . . . 1.0 112.995 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.68 75.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.758 1.021 . . . . 1.0 113.758 -172.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -66.41 -41.46 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.272 -0.892 . . . . 1.0 111.597 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.33 -45.54 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.426 0.69 . . . . 1.0 110.263 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -57.89 -50.85 71.92 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.157 1.383 . . . . 1.0 111.44 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -65.07 -36.39 84.17 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.847 0.684 . . . . 1.0 112.847 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.18 99.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 1.0 112.15 172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.4 mtp -64.99 -40.52 95.08 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -94.89 -31.33 13.74 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -111.87 -16.25 13.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 -177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -111.77 -3.43 14.96 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.062 0.945 . . . . 1.0 112.847 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.39 17.24 63.92 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.613 1.102 . . . . 1.0 115.016 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -73.21 170.69 14.44 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.698 1.199 . . . . 1.0 113.453 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -124.25 164.51 19.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.753 1.621 . . . . 1.0 109.862 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.91 -25.94 67.09 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.403 1.081 . . . . 1.0 113.434 -170.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.92 -23.13 60.97 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.231 1.197 . . . . 1.0 114.231 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.37 -17.23 64.65 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.386 0.993 . . . . 1.0 113.185 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.66 -14.13 8.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.502 1.921 . . . . 1.0 113.079 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.6 137.25 56.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.217 2.207 . . . . 1.0 112.791 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.55 -10.71 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 115.956 1.836 . . . . 1.0 115.956 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -134.59 -72.42 0.48 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.412 1.264 . . . . 1.0 114.412 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.86 140.96 15.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.118 0.967 . . . . 1.0 111.07 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 tp -141.55 27.28 1.89 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.83 1.252 . . . . 1.0 112.519 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 C--O 1.255 1.393 0 C-N-CA 125.825 1.65 . . . . 1.0 113.489 176.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 111.516 0.191 . . . . 1.0 111.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.55 168.27 23.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.305 1.442 . . . . 1.0 112.182 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -147.94 138.87 13.29 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 125.5 1.52 . . . . 1.0 111.061 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 175.59 10.46 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.602 2.868 . . . . 1.0 112.327 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.82 157.57 43.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.216 1.006 . . . . 1.0 112.738 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -141.27 -29.81 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.515 1.926 . . . . 1.0 112.765 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -129.9 155.68 45.63 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.423 1.889 . . . . 1.0 110.549 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.9 m -136.05 150.67 49.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.187 1.395 . . . . 1.0 111.467 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -140.53 168.48 19.7 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 52.1 t -123.59 132.58 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 128.347 2.659 . . . . 1.0 109.594 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.46 -54.8 5.36 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.063 -0.398 . . . . 1.0 111.812 172.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -160.04 -58.2 0.06 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.718 1.207 . . . . 1.0 111.927 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -74.72 -23.48 58.59 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.95 -172.35 42.64 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.49 1.043 . . . . 1.0 113.362 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.26 127.07 12.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.189 1.396 . . . . 1.0 111.424 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.2 m -117.86 -59.26 1.93 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.846 1.258 . . . . 1.0 113.101 -168.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -148.23 167.97 23.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.102 0.961 . . . . 1.0 111.801 -173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -129.99 162.81 27.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.883 1.273 . . . . 1.0 112.763 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -147.31 159.84 43.2 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.347 1.459 . . . . 1.0 111.222 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.9 p -114.18 -2.63 13.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.982 1.713 . . . . 1.0 113.982 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.62 25.31 47.01 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.466 -0.63 . . . . 1.0 113.796 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -135.67 163.19 30.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.533 1.533 . . . . 1.0 112.103 -174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.24 -96.31 0.79 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.485 1.041 . . . . 1.0 112.136 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.05 149.41 39.91 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.08 1.752 . . . . 1.0 111.126 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.7 m -59.51 130.09 87.5 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 124.883 1.273 . . . . 1.0 111.477 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.36 144.57 39.5 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.441 3.427 . . . . 1.0 113.866 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.04 -46.62 71.94 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.974 0.909 . . . . 1.0 113.398 -173.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.3 t -60.63 -44.81 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.485 -0.759 . . . . 1.0 111.558 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.79 -45.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.598 0.759 . . . . 1.0 110.486 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -56.87 -49.55 75.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.64 1.576 . . . . 1.0 111.59 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -64.32 -41.19 96.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.26 0.624 . . . . 1.0 112.578 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.24 90.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.625 0.77 . . . . 1.0 112.946 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.1 mtp -61.28 -45.24 95.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.729 -0.607 . . . . 1.0 112.52 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -90.51 -22.62 21.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.123 1.527 . . . . 1.0 115.123 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -110.74 -16.8 13.51 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.45 1.278 . . . . 1.0 114.45 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -127.29 -2.8 6.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.274 1.029 . . . . 1.0 113.63 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.55 13.17 67.97 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.454 1.025 . . . . 1.0 115.325 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -69.16 164.86 21.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.506 1.122 . . . . 1.0 111.703 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.32 161.03 29.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.181 1.392 . . . . 1.0 111.896 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -59.87 -36.32 76.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.331 0.652 . . . . 1.0 112.063 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -62.36 -22.83 66.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.635 1.174 . . . . 1.0 113.397 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.7 -11.1 60.49 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.061 0.846 . . . . 1.0 113.171 173.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -114.44 -18.6 11.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.534 1.933 . . . . 1.0 112.695 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.22 126.9 30.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.531 1.932 . . . . 1.0 110.846 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -26.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 116.317 1.969 . . . . 1.0 116.317 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -87.28 -7.1 58.21 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.222 1.564 . . . . 1.0 115.222 -169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -137.93 21.53 2.84 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 1.0 112.945 -173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -138.02 160.23 39.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.765 1.626 . . . . 1.0 111.458 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.256 1.425 0 C-N-CA 126.269 1.827 . . . . 1.0 112.291 -178.743 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.7 167.53 24.4 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.454 1.501 . . . . 1.0 112.106 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.06 154.09 93.26 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.802 0.841 . . . . 1.0 111.347 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.62 153.88 64.69 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.998 2.466 . . . . 1.0 111.895 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.82 152.47 45.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.445 -0.785 . . . . 1.0 112.329 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -141.49 -15.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.223 1.409 . . . . 1.0 114.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.56 157.44 44.71 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.355 1.062 . . . . 1.0 110.991 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.2 p -151.65 162.63 40.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.057 0.943 . . . . 1.0 113.254 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -147.22 163.77 35.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.776 1.399 . . . . 1.0 114.776 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.36 149.07 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 128.358 2.663 . . . . 1.0 108.893 -169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.54 -172.94 3.64 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.127 1.371 . . . . 1.0 110.814 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -57.81 -31.58 66.74 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.692 -1.255 . . . . 1.0 113.39 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -72.98 -15.61 61.54 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.134 1.161 . . . . 1.0 114.134 175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.7 -160.68 15.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.315 1.436 . . . . 1.0 112.498 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -51.08 130.3 25.7 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.735 -0.862 . . . . 1.0 110.302 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.9 m -112.71 -67.31 1.01 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -168.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -151.41 164.79 35.95 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.504 1.047 . . . . 1.0 113.225 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.7 p -114.8 163.44 15.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.938 2.095 . . . . 1.0 111.433 170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -146.52 158.04 43.83 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.099 1.36 . . . . 1.0 111.192 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.2 p -108.32 -18.47 13.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.589 1.556 . . . . 1.0 113.8 -169.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.56 -9.24 60.54 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.926 1.25 . . . . 1.0 113.797 -169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -77.55 145.57 36.83 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.602 1.201 . . . . 1.0 111.516 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.35 -169.24 44.2 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.497 0.57 . . . . 1.0 113.898 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -68.36 151.84 46.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.734 0.814 . . . . 1.0 111.79 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.4 m -57.08 134.02 80.49 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.967 1.307 . . . . 1.0 111.73 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.82 141.99 43.41 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.939 3.093 . . . . 1.0 113.748 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.98 80.29 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 -170.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.11 -31.38 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.284 -0.885 . . . . 1.0 112.83 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.19 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -57.26 -46.06 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.725 0.81 . . . . 1.0 111.29 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptp -65.95 -41.41 91.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 119.041 -0.504 . . . . 1.0 112.003 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.55 96.78 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.205 0.911 . . . . 1.0 112.306 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 94.1 mtp -62.4 -38.6 90.26 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.574 0.749 . . . . 1.0 112.536 174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.4 -51.59 19.71 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.71 -25.06 56.3 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.962 1.097 . . . . 1.0 113.962 -170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -126.22 1.68 7.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.75 1.019 . . . . 1.0 113.75 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.21 11.5 61.58 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.394 0.997 . . . . 1.0 114.921 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.86 163.4 5.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.082 1.353 . . . . 1.0 112.436 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -123.7 154.41 39.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.151 1.381 . . . . 1.0 110.101 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.54 -26.09 67.72 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.334 1.054 . . . . 1.0 113.742 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.9 -20.69 58.71 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.03 -25.26 67.77 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.565 1.075 . . . . 1.0 113.103 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.53 -20.37 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.619 1.568 . . . . 1.0 112.646 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.44 121.24 15.91 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.802 1.641 . . . . 1.0 110.482 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -126.18 -4.73 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 116.379 1.992 . . . . 1.0 116.379 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -62.13 -42.84 99.63 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 119.879 1.218 . . . . 1.0 113.982 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -143.79 21.94 1.79 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.244 1.202 . . . . 1.0 114.244 -168.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.8 mt -122.5 21.03 10.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.505 1.522 . . . . 1.0 112.88 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.742 2.017 . . . . 1.0 112.095 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.598 0.221 . . . . 1.0 111.598 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.18 167.22 25.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.235 1.414 . . . . 1.0 112.296 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -142.66 66.64 18.36 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.491 1.516 . . . . 1.0 111.293 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.32 161.82 43.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.393 2.729 . . . . 1.0 112.891 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.89 171.52 16.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.281 1.432 . . . . 1.0 112.262 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -121.32 -25.12 5.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.433 1.893 . . . . 1.0 113.063 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -136.75 154.68 50.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.817 1.247 . . . . 1.0 110.948 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.6 m -139.54 138.96 36.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.532 1.933 . . . . 1.0 109.889 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -145.6 169.87 17.58 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 -170.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.9 t -119.0 158.02 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 127.671 2.389 . . . . 1.0 111.077 -169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.57 -45.74 1.19 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.418 0.895 . . . . 1.0 113.418 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -148.66 -53.91 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.157 1.54 . . . . 1.0 115.157 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -107.84 2.05 23.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 152.4 -177.59 30.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.901 1.238 . . . . 1.0 112.818 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.51 123.57 15.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.802 -0.822 . . . . 1.0 109.953 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.7 t -118.05 -37.75 3.34 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -168.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -146.61 169.57 18.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.38 1.072 . . . . 1.0 112.295 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.0 p -138.35 162.98 33.01 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.375 1.47 . . . . 1.0 112.207 -173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -148.93 158.17 43.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.682 1.193 . . . . 1.0 111.657 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.4 p -107.42 -20.73 13.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.755 1.622 . . . . 1.0 114.179 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.7 -12.13 53.56 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.028 1.299 . . . . 1.0 114.095 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -83.23 149.36 26.86 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.647 1.224 . . . . 1.0 111.25 174.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.0 -172.99 35.96 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 123.448 0.546 . . . . 1.0 113.521 -172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -65.46 151.96 45.1 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.714 -0.874 . . . . 1.0 112.323 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -58.81 134.43 86.74 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.33 1.052 . . . . 1.0 111.207 174.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.31 135.74 31.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 124.07 3.18 . . . . 1.0 113.462 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.33 -43.95 79.5 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.312 0.856 . . . . 1.0 113.312 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.68 -34.47 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.25 -0.906 . . . . 1.0 112.963 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.27 -50.02 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.214 0.915 . . . . 1.0 109.571 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -53.66 -48.26 69.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.893 0.877 . . . . 1.0 111.23 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -66.04 -42.16 89.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.037 0.535 . . . . 1.0 112.318 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.36 98.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.372 0.669 . . . . 1.0 112.376 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 55.5 mtm -61.52 -41.45 97.33 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.629 -0.669 . . . . 1.0 112.681 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -70.17 -43.6 70.49 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -80.6 -25.24 38.57 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.414 1.265 . . . . 1.0 114.414 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -126.64 2.31 6.81 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.764 1.024 . . . . 1.0 113.764 -170.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.35 2.42 63.09 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.773 1.178 . . . . 1.0 115.281 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -58.77 162.33 4.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.546 1.539 . . . . 1.0 112.659 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -131.56 172.64 11.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.367 1.867 . . . . 1.0 109.84 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.77 -32.43 69.29 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.458 -1.401 . . . . 1.0 112.805 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.28 -21.88 65.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -71.28 -11.85 61.14 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -122.21 -17.79 7.04 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.998 1.719 . . . . 1.0 112.36 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.77 141.97 51.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.941 2.096 . . . . 1.0 113.409 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.99 -6.66 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 115.494 1.664 . . . . 1.0 115.494 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -133.03 -84.03 0.47 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.753 1.16 . . . . 1.0 112.267 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.78 144.75 15.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.873 1.269 . . . . 1.0 111.456 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.82 143.01 46.11 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.88 1.272 . . . . 1.0 111.777 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.112 1.765 . . . . 1.0 112.305 177.037 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.76 168.26 23.4 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.266 1.427 . . . . 1.0 112.138 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -66.06 158.21 77.33 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.514 1.126 . . . . 1.0 112.134 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -53.07 149.81 26.09 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.662 2.908 . . . . 1.0 114.276 170.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.98 163.19 28.3 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.361 0.874 . . . . 1.0 113.361 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -137.05 -17.26 1.39 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.409 1.883 . . . . 1.0 113.779 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -127.66 153.8 46.03 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.636 1.175 . . . . 1.0 110.603 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.6 t -146.45 147.85 31.66 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.146 1.378 . . . . 1.0 111.665 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -146.85 173.97 11.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.452 1.101 . . . . 1.0 113.293 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.47 174.44 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 127.163 2.185 . . . . 1.0 113.103 -169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.85 -49.1 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.537 0.735 . . . . 1.0 112.789 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -151.52 -62.11 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.907 0.776 . . . . 1.0 112.699 173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -77.31 -20.24 55.24 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.321 1.23 . . . . 1.0 114.321 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.24 -163.57 34.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.789 1.185 . . . . 1.0 112.54 -172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -48.51 128.47 14.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.104 0.962 . . . . 1.0 111.975 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 t -117.65 -45.29 2.7 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.902 0.881 . . . . 1.0 113.306 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -152.84 163.49 39.66 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.969 1.307 . . . . 1.0 111.967 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.8 p -130.88 164.83 24.39 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.812 1.645 . . . . 1.0 112.3 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -147.4 158.43 43.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.48 1.112 . . . . 1.0 112.243 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.0 p -100.79 -16.02 17.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.731 2.012 . . . . 1.0 114.229 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.75 12.42 60.72 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.143 0.878 . . . . 1.0 114.13 -169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -122.18 159.49 27.14 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.763 1.225 . . . . 1.0 112.205 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 -105.25 2.02 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 121.433 -0.792 . . . . 1.0 111.677 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -138.1 152.53 48.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.471 1.508 . . . . 1.0 111.06 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -58.65 132.19 85.86 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.731 1.212 . . . . 1.0 112.007 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.84 142.1 33.94 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.245 3.297 . . . . 1.0 114.054 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.41 -43.69 79.61 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.4 -43.81 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.578 -0.701 . . . . 1.0 111.54 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.9 -49.61 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.712 0.805 . . . . 1.0 109.853 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -55.08 -49.96 70.38 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.15 0.98 . . . . 1.0 111.235 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -66.17 -41.15 90.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.99 0.516 . . . . 1.0 112.09 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.91 -43.61 98.48 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.241 0.616 . . . . 1.0 112.336 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mtp -60.63 -47.26 87.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.352 0.661 . . . . 1.0 112.687 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.23 -32.39 55.8 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.526 1.306 . . . . 1.0 114.526 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -86.82 -26.99 23.8 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.206 1.188 . . . . 1.0 114.206 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -119.46 -0.13 10.95 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 15.37 72.35 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.27 0.938 . . . . 1.0 114.487 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -64.13 168.16 5.71 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.862 1.265 . . . . 1.0 112.861 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.93 154.59 46.4 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.751 1.62 . . . . 1.0 109.689 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.18 -26.98 65.27 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.77 1.228 . . . . 1.0 113.595 -171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.16 -20.31 62.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.44 -15.29 63.59 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 119.496 1.044 . . . . 1.0 113.088 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -118.57 -21.34 8.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.625 1.97 . . . . 1.0 112.575 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tt -63.86 120.22 11.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.757 1.623 . . . . 1.0 109.437 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.01 -18.83 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 116.859 2.17 . . . . 1.0 116.859 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -68.67 -30.03 68.62 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 120.628 1.558 . . . . 1.0 113.991 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -121.38 7.18 10.13 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.2 mt -132.16 25.38 4.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.13 1.372 . . . . 1.0 113.022 -171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.639 1.975 . . . . 1.0 112.305 175.47 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.497 0.189 . . . . 1.0 111.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.13 -21.56 58.76 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.792 1.404 . . . . 1.0 114.792 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -135.78 65.85 61.23 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.882 1.673 . . . . 1.0 111.76 -174.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -68.04 163.26 36.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.456 2.771 . . . . 1.0 112.956 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.88 166.88 6.74 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.234 1.014 . . . . 1.0 113.605 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.85 -24.87 2.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.181 1.792 . . . . 1.0 113.637 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -139.14 159.05 43.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.05 1.34 . . . . 1.0 110.683 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.7 p -149.77 153.76 37.38 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.118 0.967 . . . . 1.0 112.396 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -140.32 167.78 21.35 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.349 1.24 . . . . 1.0 114.349 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.4 p -130.11 159.82 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.191 2.196 . . . . 1.0 111.743 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.92 -172.68 4.22 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.322 1.449 . . . . 1.0 110.552 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -60.63 -28.93 68.93 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.267 -1.521 . . . . 1.0 113.309 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.25 -5.8 38.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.232 1.413 . . . . 1.0 114.563 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.05 -156.26 16.87 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.964 1.269 . . . . 1.0 112.851 -175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -48.48 126.96 12.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.798 0.839 . . . . 1.0 109.477 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.3 m -112.68 -71.31 0.76 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.324 1.231 . . . . 1.0 114.324 -168.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -149.51 169.25 21.34 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 119.595 1.089 . . . . 1.0 113.277 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -127.93 159.94 33.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.699 2.0 . . . . 1.0 111.764 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -151.09 158.34 43.92 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.218 1.407 . . . . 1.0 111.375 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -120.27 -11.6 9.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.193 0.997 . . . . 1.0 113.257 -173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.45 -18.3 25.33 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.386 1.47 . . . . 1.0 114.061 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -72.79 145.69 46.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.196 1.398 . . . . 1.0 111.967 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.57 -171.46 49.65 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.891 0.758 . . . . 1.0 114.604 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -60.18 136.38 58.01 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.525 1.13 . . . . 1.0 111.347 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -54.23 128.81 58.95 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.187 1.395 . . . . 1.0 111.949 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.62 147.93 56.83 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.772 2.981 . . . . 1.0 113.43 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.66 -46.13 73.95 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.203 1.186 . . . . 1.0 114.203 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.91 -42.69 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.431 -0.793 . . . . 1.0 111.432 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -47.27 93.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.397 1.079 . . . . 1.0 110.435 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -53.71 -52.52 59.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.375 1.87 . . . . 1.0 111.065 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -64.96 -43.58 92.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.458 1.103 . . . . 1.0 112.261 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.14 91.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.943 0.897 . . . . 1.0 113.059 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 53.6 mtm -71.61 -43.51 66.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.971 0.73 . . . . 1.0 112.971 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -86.9 -32.9 19.93 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.623 1.342 . . . . 1.0 114.623 -172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -115.53 -9.84 11.99 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.502 1.297 . . . . 1.0 114.502 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -121.14 -0.34 9.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.556 1.142 . . . . 1.0 113.315 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.2 12.2 79.56 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.936 1.134 . . . . 1.0 115.936 170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -77.52 -179.24 5.69 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.743 1.272 . . . . 1.0 112.234 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -136.93 168.62 19.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.984 1.713 . . . . 1.0 110.148 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.47 -26.33 65.16 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -59.23 -26.59 65.01 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.65 -14.95 63.1 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.82 -17.68 7.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.986 2.114 . . . . 1.0 113.111 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.76 136.14 55.29 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.984 2.513 . . . . 1.0 112.683 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.12 -7.43 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -131.81 -76.38 0.51 Allowed 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.216 1.191 . . . . 1.0 114.216 -169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.86 141.74 14.46 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.556 1.142 . . . . 1.0 110.975 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.77 27.17 1.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.257 1.023 . . . . 1.0 112.942 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.391 1.876 . . . . 1.0 112.624 -176.344 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 111.678 0.251 . . . . 1.0 111.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 168.2 23.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.375 1.47 . . . . 1.0 112.147 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -143.91 73.73 16.56 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.3 1.44 . . . . 1.0 112.756 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.79 155.56 10.57 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.673 2.915 . . . . 1.0 114.275 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 152.51 40.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.616 -0.678 . . . . 1.0 112.609 172.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -140.18 -10.16 1.12 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.962 1.705 . . . . 1.0 113.674 175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -137.94 156.23 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.91 1.684 . . . . 1.0 111.568 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.9 t -147.91 148.28 30.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.425 1.49 . . . . 1.0 111.598 174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -139.14 160.42 39.83 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.28 153.42 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 127.641 2.376 . . . . 1.0 110.371 -168.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.94 -171.84 3.44 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.465 1.506 . . . . 1.0 110.641 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.35 -38.61 66.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.533 -1.355 . . . . 1.0 113.685 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -77.53 -12.71 59.99 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.885 1.274 . . . . 1.0 114.048 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.85 -162.83 20.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.378 1.466 . . . . 1.0 113.185 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -48.49 129.04 15.74 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.187 0.995 . . . . 1.0 110.449 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.9 m -110.79 -65.51 1.16 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.305 0.854 . . . . 1.0 113.305 -168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -152.15 164.5 37.18 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 119.262 0.937 . . . . 1.0 112.539 -174.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.6 p -119.14 161.86 19.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.162 1.785 . . . . 1.0 111.601 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -148.72 157.95 43.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.976 1.31 . . . . 1.0 111.03 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.4 p -97.75 -20.28 17.67 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.476 1.511 . . . . 1.0 113.57 -171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.74 -10.27 62.45 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.194 1.378 . . . . 1.0 113.252 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -81.25 144.11 31.8 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.814 1.245 . . . . 1.0 111.578 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.04 -168.27 47.7 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 123.761 0.696 . . . . 1.0 113.802 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -61.22 146.25 48.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.923 0.889 . . . . 1.0 112.623 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m -61.97 133.06 93.79 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 124.854 1.262 . . . . 1.0 111.729 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.38 144.43 40.15 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.279 3.319 . . . . 1.0 113.685 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.22 78.07 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.181 1.178 . . . . 1.0 114.181 -169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -62.4 -42.65 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 O-C-N 121.074 -1.016 . . . . 1.0 111.399 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.75 -50.61 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.568 0.747 . . . . 1.0 109.73 176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -40.85 96.5 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.303 -0.873 . . . . 1.0 112.281 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -65.15 -39.0 92.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.613 1.165 . . . . 1.0 112.304 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.22 -32.94 73.67 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.122 0.874 . . . . 1.0 112.741 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 13.1 mmt -64.8 -50.23 67.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.318 -0.864 . . . . 1.0 112.0 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.73 -23.14 23.02 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.241 1.571 . . . . 1.0 115.241 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -108.9 -16.85 14.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.491 1.116 . . . . 1.0 113.863 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -128.72 2.36 5.46 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.546 1.139 . . . . 1.0 113.226 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.62 20.68 72.21 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.357 0.98 . . . . 1.0 115.337 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -67.61 175.35 2.93 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.333 1.067 . . . . 1.0 113.375 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -131.5 160.54 34.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.721 2.008 . . . . 1.0 108.784 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.81 -31.32 66.49 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.208 1.003 . . . . 1.0 112.996 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.2 -20.52 62.86 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.64 -21.91 66.61 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.096 0.862 . . . . 1.0 113.052 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -120.46 -16.73 8.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.42 1.488 . . . . 1.0 113.188 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 16.3 tp -64.93 140.45 58.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.19 1.796 . . . . 1.0 111.59 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.23 -14.04 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 116.569 2.062 . . . . 1.0 116.569 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -134.96 18.66 3.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.149 1.907 . . . . 1.0 116.149 -169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -143.49 49.49 1.41 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.387 1.075 . . . . 1.0 111.402 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.76 17.15 8.06 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.917 1.287 . . . . 1.0 113.278 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.376 0 C-N-CA 125.841 1.656 . . . . 1.0 113.391 177.409 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.578 0.227 . . . . 1.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.73 167.89 24.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.317 1.447 . . . . 1.0 112.123 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -135.57 63.4 53.72 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.879 1.671 . . . . 1.0 111.605 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.77 157.85 59.13 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.333 2.689 . . . . 1.0 112.689 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.1 171.81 17.86 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.037 1.335 . . . . 1.0 112.46 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -127.46 -21.12 3.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.187 1.795 . . . . 1.0 113.318 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -136.14 157.99 45.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.486 1.114 . . . . 1.0 111.14 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 t -146.78 147.08 30.54 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.628 1.571 . . . . 1.0 111.125 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -138.59 163.29 32.43 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.5 t -120.02 150.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.842 2.057 . . . . 1.0 111.48 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -146.13 -162.71 1.58 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.507 1.923 . . . . 1.0 109.509 173.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.76 -20.4 56.39 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 119.837 -1.789 . . . . 1.0 113.926 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -72.98 -12.97 61.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.93 1.292 . . . . 1.0 113.884 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.33 -140.04 14.95 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 106.842 -2.503 . . . . 1.0 106.842 -167.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -52.16 124.58 13.4 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.115 1.458 . . . . 1.0 108.609 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.39 -59.31 1.95 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.739 1.385 . . . . 1.0 114.739 -167.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -148.78 164.78 33.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.066 0.947 . . . . 1.0 112.421 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 75.0 p -133.65 162.97 30.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.538 1.535 . . . . 1.0 112.496 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -149.68 157.54 43.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.672 1.189 . . . . 1.0 111.949 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.5 p -107.57 -17.76 14.02 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.497 1.519 . . . . 1.0 113.679 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.41 -12.27 51.19 Favored Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.094 1.33 . . . . 1.0 113.756 -170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -72.9 143.06 47.87 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.484 1.142 . . . . 1.0 111.767 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.52 -167.04 41.45 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 123.732 0.682 . . . . 1.0 114.307 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -66.79 150.46 49.1 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.926 0.89 . . . . 1.0 112.02 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.1 m -57.31 133.38 81.27 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.031 1.333 . . . . 1.0 112.174 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.78 144.11 36.02 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.512 3.475 . . . . 1.0 113.68 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.44 -45.84 76.78 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.931 1.086 . . . . 1.0 113.931 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.53 -42.82 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.326 -0.859 . . . . 1.0 111.401 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.72 -48.69 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.477 0.711 . . . . 1.0 110.164 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -61.07 -41.74 97.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.541 -0.725 . . . . 1.0 112.033 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -66.76 -39.88 88.03 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.892 0.877 . . . . 1.0 112.266 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.69 98.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.807 0.731 . . . . 1.0 112.772 172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.9 mtp -59.32 -44.48 92.59 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.544 -0.723 . . . . 1.0 112.17 173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -74.13 -38.11 63.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.562 1.319 . . . . 1.0 114.562 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -104.47 -15.2 15.44 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.6 1.333 . . . . 1.0 114.6 -169.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -122.34 2.18 9.69 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.591 1.156 . . . . 1.0 112.727 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.39 16.44 67.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.691 1.138 . . . . 1.0 114.572 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -70.36 171.62 9.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.197 1.399 . . . . 1.0 114.181 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -130.44 164.54 24.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.422 2.289 . . . . 1.0 111.28 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.1 mt -61.31 -25.21 66.97 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.77 -22.42 64.05 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.07 -16.84 64.28 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 119.201 0.91 . . . . 1.0 113.414 170.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -121.71 -17.91 7.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.613 1.965 . . . . 1.0 112.971 -175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.5 tp -53.86 141.46 27.22 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.816 2.046 . . . . 1.0 113.069 174.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -4.72 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.803 1.779 . . . . 1.0 115.803 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.97 -82.11 0.48 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.504 1.047 . . . . 1.0 112.119 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.52 143.36 16.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.052 1.741 . . . . 1.0 109.264 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.1 tp -78.55 38.27 0.31 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.58 1.152 . . . . 1.0 113.204 -173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.365 0 C-N-CA 125.986 1.714 . . . . 1.0 114.249 175.751 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 111.8 0.296 . . . . 1.0 111.8 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.15 17.74 2.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.567 1.147 . . . . 1.0 114.094 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -143.42 81.91 11.98 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 125.362 1.465 . . . . 1.0 111.441 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -53.43 160.68 4.73 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.28 3.32 . . . . 1.0 115.249 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.99 173.99 12.76 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.868 1.667 . . . . 1.0 111.443 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -134.01 -19.67 1.99 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.777 1.399 . . . . 1.0 114.777 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -130.78 164.74 24.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.526 1.13 . . . . 1.0 110.649 -176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 96.1 p -153.84 162.22 41.4 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.383 1.073 . . . . 1.0 112.762 170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -143.91 173.22 11.89 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.593 0.96 . . . . 1.0 113.593 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.81 158.18 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.556 2.342 . . . . 1.0 113.475 -168.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -148.99 -166.01 2.44 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.581 1.953 . . . . 1.0 110.482 170.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -56.58 -36.37 69.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.042 -1.661 . . . . 1.0 113.952 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -70.33 -16.54 63.01 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.443 1.275 . . . . 1.0 114.443 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.68 -151.33 17.79 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 108.777 -1.729 . . . . 1.0 108.777 -168.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -50.02 127.67 17.1 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.904 -1.35 . . . . 1.0 110.923 169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.9 t -103.93 -45.16 4.84 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 118.38 -0.819 . . . . 1.0 112.839 -169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -164.13 171.54 14.94 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.68 1.363 . . . . 1.0 114.68 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -100.34 165.68 11.34 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.723 2.009 . . . . 1.0 111.809 171.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -148.49 158.25 43.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.285 1.434 . . . . 1.0 111.641 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.7 p -108.45 -14.01 14.74 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.227 1.411 . . . . 1.0 114.345 -171.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.08 -9.9 65.61 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.569 1.081 . . . . 1.0 113.736 -170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -76.41 143.12 40.82 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.402 1.101 . . . . 1.0 111.823 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.83 -170.3 51.65 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 123.652 0.644 . . . . 1.0 113.927 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -68.15 151.59 46.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.87 0.868 . . . . 1.0 111.568 175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 32.4 m -56.13 132.08 74.75 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.842 1.257 . . . . 1.0 111.939 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.14 144.27 38.68 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.85 3.033 . . . . 1.0 114.144 176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.68 -44.5 77.37 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.125 1.157 . . . . 1.0 114.125 -170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.6 -40.51 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.416 -0.802 . . . . 1.0 111.795 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.34 -45.62 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.401 0.68 . . . . 1.0 110.076 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -57.76 -44.64 86.29 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.492 1.117 . . . . 1.0 111.761 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -61.46 -41.63 97.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.537 0.735 . . . . 1.0 112.283 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.31 87.19 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.686 0.795 . . . . 1.0 112.943 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 48.8 mtt -61.38 -34.33 75.14 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.153 0.797 . . . . 1.0 113.153 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -100.25 -25.01 14.4 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.641 1.719 . . . . 1.0 115.641 -175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.62 -16.76 13.18 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.751 1.389 . . . . 1.0 114.751 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -115.62 -1.66 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.132 0.973 . . . . 1.0 112.781 173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.45 19.53 62.4 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.141 1.353 . . . . 1.0 114.616 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -73.98 167.58 21.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.857 1.263 . . . . 1.0 114.059 -173.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -119.87 159.86 23.8 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.392 1.877 . . . . 1.0 109.426 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.28 -25.6 67.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.813 1.042 . . . . 1.0 113.813 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.57 -21.7 64.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.785 1.031 . . . . 1.0 113.785 175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.94 -18.56 65.42 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 119.863 1.211 . . . . 1.0 112.775 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -116.4 -16.15 10.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.693 1.997 . . . . 1.0 112.554 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.96 124.22 22.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.862 1.665 . . . . 1.0 109.631 169.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.61 -12.83 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 116.555 2.057 . . . . 1.0 116.555 -171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.48 -51.66 40.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.024 1.283 . . . . 1.0 112.912 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.75 133.17 7.04 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.683 1.193 . . . . 1.0 111.01 -175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.9 mt -138.13 21.66 2.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.385 1.474 . . . . 1.0 112.579 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.205 1.402 . . . . 1.0 113.85 178.051 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.828 0.307 . . . . 1.0 111.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.49 18.78 3.34 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.902 1.281 . . . . 1.0 113.776 -174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -52.73 -35.67 26.94 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 115.961 1.838 . . . . 1.0 115.961 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -65.58 36.97 0.12 Allowed 'Trans proline' 0 CA--C 1.551 1.354 1 C-N-CA 125.873 4.382 . . . . 1.0 116.27 171.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.0 152.34 28.15 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.755 -1.215 . . . . 1.0 114.028 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -137.68 -10.61 1.6 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.518 1.927 . . . . 1.0 113.426 169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -128.66 150.57 50.19 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.441 1.096 . . . . 1.0 110.049 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.7 t -146.32 143.14 28.93 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.152 1.381 . . . . 1.0 111.472 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -142.76 169.08 18.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.467 1.107 . . . . 1.0 113.541 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.41 153.53 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.713 2.405 . . . . 1.0 110.899 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -119.69 -52.4 2.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.983 0.913 . . . . 1.0 112.546 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -144.44 -60.15 0.38 Allowed 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.98 -25.68 61.94 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.223 1.194 . . . . 1.0 114.223 -169.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.83 -173.47 35.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.391 1.472 . . . . 1.0 111.929 -173.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -48.53 103.05 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.362 1.065 . . . . 1.0 111.121 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 t -88.55 -37.96 15.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.602 1.161 . . . . 1.0 112.13 -169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -151.89 160.35 43.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.674 1.19 . . . . 1.0 112.05 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.3 p -128.19 163.93 23.61 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.9 1.68 . . . . 1.0 112.383 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -148.77 154.53 39.7 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.795 1.238 . . . . 1.0 112.038 -174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.7 p -84.7 -19.08 33.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.081 2.153 . . . . 1.0 114.129 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.68 13.08 70.76 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.943 0.783 . . . . 1.0 113.384 -169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -122.65 155.01 37.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.243 1.417 . . . . 1.0 111.555 -176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.03 -169.24 49.28 Favored Glycine 0 CA--C 1.54 1.617 0 O-C-N 121.836 -0.54 . . . . 1.0 112.549 -169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -58.99 140.99 55.07 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.737 -0.861 . . . . 1.0 112.639 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.4 m -60.62 128.02 87.81 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.623 1.169 . . . . 1.0 111.4 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 149.71 53.65 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.64 2.894 . . . . 1.0 113.694 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.61 -47.08 77.13 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.08 1.141 . . . . 1.0 114.08 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.38 -42.43 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.266 -0.896 . . . . 1.0 111.667 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.2 mm -60.25 -48.88 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.758 0.823 . . . . 1.0 109.889 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -55.59 -50.66 69.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.953 1.301 . . . . 1.0 111.327 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -63.61 -40.64 97.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.609 0.763 . . . . 1.0 112.146 -175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.29 90.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.214 1.006 . . . . 1.0 113.353 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.19 -43.83 97.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.098 -1.001 . . . . 1.0 112.164 172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -74.15 -42.6 59.69 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.614 1.339 . . . . 1.0 114.614 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -113.25 -13.99 12.9 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -169.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -120.1 2.28 10.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.336 1.055 . . . . 1.0 112.052 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.45 66.89 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.119 -0.988 . . . . 1.0 115.021 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -68.93 172.27 6.83 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.468 1.134 . . . . 1.0 113.383 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -137.1 160.42 39.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.078 2.151 . . . . 1.0 108.495 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -56.07 -30.56 62.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.64 1.176 . . . . 1.0 113.318 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -62.31 -21.29 65.14 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.397 1.079 . . . . 1.0 113.875 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.41 -21.46 66.67 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.512 1.051 . . . . 1.0 112.456 170.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.92 -18.76 10.64 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.699 1.999 . . . . 1.0 112.82 -174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 tt -59.83 123.73 17.92 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.68 1.992 . . . . 1.0 110.156 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 -15.65 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 117.082 2.252 . . . . 1.0 117.082 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -95.56 -29.47 14.33 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 115.435 1.643 . . . . 1.0 115.435 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.28 33.04 3.89 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.247 1.019 . . . . 1.0 113.263 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.3 mt -67.54 -17.42 64.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.744 1.016 . . . . 1.0 113.744 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.853 2.061 . . . . 1.0 112.376 -178.625 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.675 0.25 . . . . 1.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.5 169.06 21.78 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.341 1.456 . . . . 1.0 112.173 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -135.34 150.15 71.7 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 125.841 1.656 . . . . 1.0 111.103 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.59 35.67 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.754 3.636 . . . . 1.0 113.488 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.98 176.57 10.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.1 1.76 . . . . 1.0 111.878 -169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -122.7 -18.44 6.57 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.536 1.534 . . . . 1.0 113.9 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -134.6 156.18 49.15 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.191 0.997 . . . . 1.0 110.75 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.5 p -151.72 156.41 40.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.016 0.926 . . . . 1.0 112.501 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.81 167.89 21.07 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.523 1.129 . . . . 1.0 112.349 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.78 141.33 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.765 1.226 . . . . 1.0 112.42 -169.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -142.05 -34.22 0.47 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.437 1.095 . . . . 1.0 112.482 169.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -143.27 -10.05 0.75 Allowed 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.694 2.109 . . . . 1.0 116.694 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -124.75 9.16 8.24 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 116.303 1.964 . . . . 1.0 116.303 -168.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.26 -42.11 1.88 Allowed Glycine 0 CA--C 1.542 1.763 0 O-C-N 120.244 -1.535 . . . . 1.0 111.97 -169.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -140.26 101.27 4.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 128.253 2.621 . . . . 1.0 107.548 168.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -86.18 -53.48 5.02 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.93 1.292 . . . . 1.0 111.972 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -143.3 163.76 32.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.909 1.284 . . . . 1.0 111.823 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.2 p -136.1 159.14 42.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.721 1.608 . . . . 1.0 111.96 -172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -152.93 157.97 41.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.426 1.09 . . . . 1.0 112.285 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.8 p -104.99 -20.08 13.64 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.408 1.483 . . . . 1.0 114.0 -174.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.45 -10.56 42.61 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.081 1.324 . . . . 1.0 113.766 -169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -76.69 142.23 40.61 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.471 1.109 . . . . 1.0 111.898 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.34 -165.37 49.63 Favored Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.755 -0.591 . . . . 1.0 113.942 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -67.16 153.03 44.66 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.01 0.924 . . . . 1.0 112.572 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.7 m -58.17 132.88 84.29 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.249 1.42 . . . . 1.0 112.217 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.09 145.55 41.92 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.232 3.288 . . . . 1.0 114.072 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.14 -44.39 79.15 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.22 1.193 . . . . 1.0 114.22 -170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.76 -41.54 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 121.458 -0.776 . . . . 1.0 111.534 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 59.5 mt -63.86 -45.91 95.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.465 0.706 . . . . 1.0 110.153 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -56.39 -46.3 80.18 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.807 1.243 . . . . 1.0 111.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -64.64 -40.1 94.86 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.912 -0.492 . . . . 1.0 112.167 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.66 81.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.741 0.816 . . . . 1.0 113.163 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 77.3 mtp -62.29 -42.71 99.59 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.623 -0.673 . . . . 1.0 112.114 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -78.22 -35.59 48.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.613 1.338 . . . . 1.0 114.613 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -111.72 -16.02 13.3 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.928 1.455 . . . . 1.0 114.928 -171.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -123.26 -1.54 8.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.3 1.04 . . . . 1.0 113.11 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.41 13.5 65.34 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.585 1.088 . . . . 1.0 114.816 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.98 173.69 8.05 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.999 1.319 . . . . 1.0 112.334 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -135.82 171.88 13.81 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.3 1.84 . . . . 1.0 109.953 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.88 -30.93 66.24 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.768 -1.207 . . . . 1.0 112.578 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -59.91 -29.92 68.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.212 1.005 . . . . 1.0 113.279 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -66.19 -12.6 57.06 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -122.47 -4.61 8.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.738 2.015 . . . . 1.0 112.82 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.1 tp -77.02 132.94 39.22 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.622 2.369 . . . . 1.0 111.806 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.11 -14.76 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -170.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -135.95 28.18 3.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.195 1.924 . . . . 1.0 116.195 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -139.7 19.6 2.51 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.979 0.912 . . . . 1.0 112.873 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.1 mt -125.68 22.93 7.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.227 1.411 . . . . 1.0 112.998 -169.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.796 2.038 . . . . 1.0 112.112 -179.637 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.697 0.258 . . . . 1.0 111.697 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.17 19.44 2.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.5 1.12 . . . . 1.0 113.794 -174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.42 150.18 90.26 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.318 1.047 . . . . 1.0 112.176 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 164.79 34.54 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.38 2.72 . . . . 1.0 112.721 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.72 171.66 16.34 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.499 1.52 . . . . 1.0 112.104 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -123.32 -28.86 3.91 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.333 1.453 . . . . 1.0 114.116 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 130' ' ' LEU . 8.1 m-85 -136.81 160.8 37.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.126 0.97 . . . . 1.0 111.107 -174.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.7 t -146.82 145.58 29.94 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.517 1.127 . . . . 1.0 111.679 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.35 163.75 31.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.849 1.426 . . . . 1.0 114.849 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.5 t -132.36 152.26 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.849 2.86 . . . . 1.0 109.625 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.04 -170.69 2.93 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.484 1.514 . . . . 1.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.2 -40.48 77.49 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.321 -1.487 . . . . 1.0 113.93 -170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -80.23 -17.66 51.67 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.104 1.15 . . . . 1.0 114.104 -175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.64 -167.36 28.14 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.941 1.258 . . . . 1.0 112.866 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -53.76 145.65 15.34 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.855 -0.791 . . . . 1.0 112.07 169.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 m -116.82 -76.19 0.57 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.96 -1.019 . . . . 1.0 113.06 -169.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 176.26 6.29 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 114.334 1.235 . . . . 1.0 114.334 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.4 p -100.34 165.03 11.67 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.944 1.698 . . . . 1.0 113.102 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -143.35 157.72 44.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.476 1.511 . . . . 1.0 111.389 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 p -108.11 -9.98 15.51 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.1 1.76 . . . . 1.0 114.637 -169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.26 17.09 65.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 123.953 0.787 . . . . 1.0 114.366 -171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -124.65 154.84 40.13 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.251 1.42 . . . . 1.0 111.508 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.78 -168.89 46.08 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 112.191 -0.363 . . . . 1.0 112.191 -169.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -64.76 140.89 58.91 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.575 -0.956 . . . . 1.0 111.49 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -58.17 133.71 84.38 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.503 1.121 . . . . 1.0 110.668 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.51 150.18 88.67 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.473 2.115 . . . . 1.0 112.025 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -48.25 -55.68 9.9 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 -35.66 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 120.957 -1.089 . . . . 1.0 112.803 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 16.3 mt -67.22 -46.77 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.139 0.576 . . . . 1.0 109.913 175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -54.66 -49.96 69.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.287 1.035 . . . . 1.0 111.488 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -63.12 -41.79 99.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.162 0.985 . . . . 1.0 111.757 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.99 92.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.788 0.835 . . . . 1.0 112.918 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.59 -46.95 80.5 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.508 -0.745 . . . . 1.0 112.19 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.72 -40.54 55.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -175.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.24 -10.71 13.32 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.115 1.524 . . . . 1.0 115.115 -169.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.06 4.45 8.62 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.588 1.155 . . . . 1.0 113.076 174.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.15 17.14 67.67 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.785 1.183 . . . . 1.0 115.304 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -68.26 169.41 10.52 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.244 1.022 . . . . 1.0 112.844 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -133.45 166.06 23.42 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.629 1.972 . . . . 1.0 108.656 169.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 30.1 mt -62.0 -24.03 66.78 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.012 -1.055 . . . . 1.0 113.829 -170.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -55.45 -23.79 27.26 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.37 -16.69 64.02 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 113.587 0.958 . . . . 1.0 113.587 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -122.18 -10.67 8.52 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.055 2.142 . . . . 1.0 113.012 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -56.1 137.33 51.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.121 2.568 . . . . 1.0 113.341 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.11 -16.71 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.218 1.562 . . . . 1.0 115.218 179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -143.52 -73.02 0.28 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -144.92 151.94 39.45 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.532 1.133 . . . . 1.0 112.526 -171.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.4 171.66 15.67 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.972 1.709 . . . . 1.0 111.01 -176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.277 1.831 . . . . 1.0 111.716 -179.93 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.03 159.76 41.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.695 1.198 . . . . 1.0 112.399 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -62.36 -46.77 90.23 Favored Pre-proline 0 N--CA 1.478 0.942 0 N-CA-C 117.331 2.345 . . . . 1.0 117.331 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.43 148.25 37.82 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.699 2.266 . . . . 1.0 113.379 -169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.63 164.53 25.83 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.272 1.029 . . . . 1.0 113.258 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -135.77 -11.61 2.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.573 1.949 . . . . 1.0 113.092 169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -132.69 157.07 45.79 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.872 1.669 . . . . 1.0 111.319 -171.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 60.3 p -145.91 158.73 43.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.318 1.047 . . . . 1.0 112.263 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -143.39 169.82 16.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.083 . . . . 1.0 112.684 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.8 m -117.73 172.27 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.69 1.996 . . . . 1.0 112.567 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.08 -46.79 0.3 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 172.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -150.03 -61.1 0.2 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.961 0.801 . . . . 1.0 113.035 174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -76.94 -21.08 55.35 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.266 1.209 . . . . 1.0 114.266 -170.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.26 -158.34 27.9 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.878 1.227 . . . . 1.0 111.56 -170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -48.69 126.98 12.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.786 0.803 . . . . 1.0 110.658 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -117.14 -52.39 2.51 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 1.0 113.039 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -143.72 165.86 26.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.913 1.285 . . . . 1.0 111.632 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.7 p -127.94 159.88 33.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.882 1.673 . . . . 1.0 112.439 -175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -149.35 154.13 38.49 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.501 1.12 . . . . 1.0 111.812 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.0 p -79.11 -21.4 46.68 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.497 1.919 . . . . 1.0 114.068 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.88 10.36 69.63 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.073 0.844 . . . . 1.0 113.884 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -130.47 159.27 37.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.117 1.367 . . . . 1.0 111.475 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.95 -166.65 52.07 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.778 -0.576 . . . . 1.0 112.22 -169.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.8 ptt180 -57.41 134.13 55.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.862 -0.787 . . . . 1.0 112.381 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.1 m -63.6 130.86 94.63 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 124.619 1.168 . . . . 1.0 111.292 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.36 143.93 32.83 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.188 3.259 . . . . 1.0 113.758 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.28 -44.79 76.0 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -170.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.39 -41.7 91.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 121.438 -0.789 . . . . 1.0 111.478 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 54.7 mt -63.62 -44.38 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.503 0.721 . . . . 1.0 110.282 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -57.74 -50.78 72.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.605 1.162 . . . . 1.0 111.409 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -62.46 -38.82 91.29 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.157 0.583 . . . . 1.0 112.099 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.52 87.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.956 0.724 . . . . 1.0 112.956 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 50.2 mtt -64.02 -48.16 77.41 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.256 -0.903 . . . . 1.0 112.255 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.99 -37.01 61.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.711 1.374 . . . . 1.0 114.711 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -111.66 -15.37 13.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.445 1.276 . . . . 1.0 114.445 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -127.66 3.21 6.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.535 1.134 . . . . 1.0 113.276 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.19 16.8 69.37 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.809 1.195 . . . . 1.0 115.439 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -67.71 168.7 10.83 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.442 1.121 . . . . 1.0 112.914 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -131.29 175.11 9.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.397 1.879 . . . . 1.0 110.363 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.19 -41.45 75.55 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.22 -0.925 . . . . 1.0 112.372 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.73 -16.55 64.32 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -67.81 -18.74 64.94 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.185 0.902 . . . . 1.0 112.94 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.73 -16.98 7.02 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.712 1.605 . . . . 1.0 113.808 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.04 121.36 14.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.172 1.789 . . . . 1.0 109.527 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -127.53 -8.71 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 116.953 2.205 . . . . 1.0 116.953 -170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.37 -35.92 82.46 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 120.199 1.363 . . . . 1.0 113.844 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.44 23.12 2.34 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.1 0.96 . . . . 1.0 112.593 -172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.69 154.22 47.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.927 1.691 . . . . 1.0 111.177 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.394 1.878 . . . . 1.0 112.368 -177.332 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.649 0.24 . . . . 1.0 111.649 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.03 169.92 19.53 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.407 1.483 . . . . 1.0 112.031 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.77 152.46 72.52 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 126.292 1.837 . . . . 1.0 111.191 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.87 158.76 49.55 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.303 2.669 . . . . 1.0 113.031 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.16 166.65 32.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.01 1.724 . . . . 1.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -139.8 -14.21 1.07 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.301 1.44 . . . . 1.0 114.408 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -129.83 154.26 47.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.77 1.228 . . . . 1.0 110.527 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.0 t -148.4 146.89 28.66 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.261 1.425 . . . . 1.0 111.38 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.77 165.59 26.88 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.1 143.22 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.307 2.243 . . . . 1.0 110.344 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -148.96 -41.01 0.15 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.578 1.151 . . . . 1.0 112.264 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -94.55 -137.49 0.21 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.065 0.946 . . . . 1.0 112.507 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -65.0 -10.92 33.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.013 1.725 . . . . 1.0 115.11 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.72 -154.14 15.62 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.971 1.748 . . . . 1.0 111.274 -174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -48.02 124.54 7.7 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.461 1.124 . . . . 1.0 110.159 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -109.23 -52.97 2.71 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.066 1.746 . . . . 1.0 112.689 -168.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -147.58 159.51 43.68 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.506 1.122 . . . . 1.0 111.582 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.1 p -125.35 163.11 23.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.735 1.614 . . . . 1.0 112.444 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -150.52 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.619 1.168 . . . . 1.0 112.294 -172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.1 p -96.46 -13.71 22.91 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.615 1.966 . . . . 1.0 114.236 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 87.92 16.33 59.78 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.04 0.829 . . . . 1.0 114.125 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -128.46 150.78 50.0 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.211 1.405 . . . . 1.0 111.411 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.54 -165.83 53.33 Favored Glycine 0 CA--C 1.539 1.587 0 O-C-N 121.923 -0.486 . . . . 1.0 113.004 -169.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -58.68 127.77 33.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.748 1.219 . . . . 1.0 111.742 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -58.02 132.61 83.69 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.579 1.152 . . . . 1.0 111.627 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.9 142.0 44.17 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.956 3.104 . . . . 1.0 113.498 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.73 -51.1 68.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.505 0.928 . . . . 1.0 113.505 -170.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.79 -41.57 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 121.261 -0.9 . . . . 1.0 111.606 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.62 -48.93 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.811 0.844 . . . . 1.0 110.212 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -57.75 -51.88 67.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.218 1.007 . . . . 1.0 111.765 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -61.78 -42.93 99.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.402 0.681 . . . . 1.0 112.16 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.24 94.29 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.5 0.72 . . . . 1.0 112.749 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.9 mtp -66.54 -39.72 88.73 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.472 -0.767 . . . . 1.0 112.777 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -92.61 -29.89 15.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.289 1.588 . . . . 1.0 115.289 -171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -112.36 -17.8 12.63 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.219 1.562 . . . . 1.0 115.219 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -115.36 3.36 14.16 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 119.166 0.894 . . . . 1.0 113.222 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.22 82.34 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.756 1.169 . . . . 1.0 115.574 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -65.64 167.88 8.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.833 1.317 . . . . 1.0 112.798 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -125.02 155.66 39.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.18 1.792 . . . . 1.0 108.541 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.3 tp -61.51 -26.77 68.14 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -60.34 -20.46 59.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.196 1.399 . . . . 1.0 113.719 173.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.05 -23.1 67.29 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.266 0.939 . . . . 1.0 112.419 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -113.46 -20.47 11.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.564 1.946 . . . . 1.0 112.821 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.34 120.29 11.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.315 1.446 . . . . 1.0 110.233 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.22 -11.99 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 116.659 2.096 . . . . 1.0 116.659 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -67.21 -49.97 62.56 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 120.172 1.351 . . . . 1.0 112.841 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -161.56 139.22 8.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.172 1.389 . . . . 1.0 111.105 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 73.4 mt -142.97 163.55 32.49 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.719 1.608 . . . . 1.0 110.872 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.217 1.807 . . . . 1.0 113.713 179.318 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.268 0.099 . . . . 1.0 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.62 160.78 40.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.456 1.102 . . . . 1.0 112.823 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -61.6 -43.29 87.97 Favored Pre-proline 0 N--CA 1.481 1.086 0 N-CA-C 117.1 2.259 . . . . 1.0 117.1 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -84.18 35.39 0.54 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.985 3.123 . . . . 1.0 113.957 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.99 171.11 17.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.779 1.632 . . . . 1.0 112.146 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -124.43 -28.5 3.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.594 1.558 . . . . 1.0 113.129 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -137.77 155.28 49.21 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.513 1.525 . . . . 1.0 110.73 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.6 t -143.33 143.22 31.59 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.392 1.477 . . . . 1.0 110.765 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -138.61 162.18 35.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.295 1.22 . . . . 1.0 114.295 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -117.21 144.65 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.35 2.26 . . . . 1.0 110.386 -169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -147.56 -44.22 0.17 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.333 1.453 . . . . 1.0 110.727 170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -73.92 -165.32 0.29 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.07 2.148 . . . . 1.0 111.305 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.32 0.37 1.47 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.297 1.839 . . . . 1.0 114.528 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.52 -165.61 28.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.956 2.217 . . . . 1.0 111.473 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -48.9 131.96 18.49 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.954 -0.733 . . . . 1.0 111.683 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -114.04 -51.98 2.75 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.894 1.677 . . . . 1.0 111.903 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -152.83 169.74 22.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.023 1.329 . . . . 1.0 111.488 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.2 p -130.69 165.47 22.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.784 1.634 . . . . 1.0 112.686 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -148.26 160.44 42.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.809 1.244 . . . . 1.0 111.784 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 p -118.73 -3.36 10.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.02 1.728 . . . . 1.0 113.91 -171.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.71 20.24 58.45 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.801 0.715 . . . . 1.0 114.222 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -128.03 152.85 47.44 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.38 1.472 . . . . 1.0 111.313 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.88 -166.57 39.89 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.928 -0.483 . . . . 1.0 112.815 -169.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.55 139.63 52.95 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.876 -0.779 . . . . 1.0 112.27 175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -62.81 127.77 90.98 Favored Pre-proline 0 N--CA 1.48 1.06 0 CA-C-O 118.198 -0.906 . . . . 1.0 110.338 171.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.62 149.33 40.29 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.548 2.832 . . . . 1.0 113.794 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -50.25 71.58 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.811 1.041 . . . . 1.0 113.811 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.2 p -72.28 -30.99 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 O-C-N 120.826 -1.171 . . . . 1.0 112.854 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.8 mm -59.66 -54.29 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.904 0.774 . . . . 1.0 109.747 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -64.1 -45.32 89.16 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.903 -0.498 . . . . 1.0 112.122 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -66.36 -34.14 77.31 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.33 -41.57 98.9 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.854 0.752 . . . . 1.0 112.42 171.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 73.6 mtm -69.89 -42.5 73.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.229 0.826 . . . . 1.0 113.229 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -77.34 -41.88 38.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.97 1.308 . . . . 1.0 114.305 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -112.34 -15.79 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -120.75 1.35 10.51 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.441 1.097 . . . . 1.0 112.993 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 16.24 72.88 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.877 1.227 . . . . 1.0 115.612 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -73.73 177.47 5.44 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.517 1.158 . . . . 1.0 111.705 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -128.21 160.47 31.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.007 1.723 . . . . 1.0 108.645 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.56 -25.85 68.27 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.146 -0.971 . . . . 1.0 112.964 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.42 -25.8 60.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.602 1.161 . . . . 1.0 113.118 171.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.25 -15.17 59.54 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.714 1.005 . . . . 1.0 113.714 173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.27 -13.53 8.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.451 1.9 . . . . 1.0 113.199 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -57.75 136.05 56.86 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.988 2.115 . . . . 1.0 112.727 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -9.27 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 115.984 1.846 . . . . 1.0 115.984 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -138.02 -75.05 0.4 Allowed 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 115.064 1.505 . . . . 1.0 115.064 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -148.37 159.0 44.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.775 1.23 . . . . 1.0 113.864 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.4 mt -121.62 24.04 9.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.944 1.298 . . . . 1.0 112.85 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.251 1.421 . . . . 1.0 112.383 169.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.897 0.332 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.3 165.72 13.5 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.492 1.117 . . . . 1.0 113.448 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -144.61 157.0 56.27 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.522 1.529 . . . . 1.0 112.031 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.69 56.53 5.97 Favored 'Trans proline' 0 CA--C 1.549 1.236 0 C-N-CA 124.632 3.555 . . . . 1.0 113.579 -173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.85 20.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.892 1.277 . . . . 1.0 112.44 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -115.31 -26.82 7.45 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.228 1.811 . . . . 1.0 112.754 -175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -138.97 156.34 47.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.09 1.756 . . . . 1.0 110.088 173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.9 p -155.7 154.33 31.34 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.431 -0.793 . . . . 1.0 112.659 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -139.72 171.68 13.88 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.951 1.093 . . . . 1.0 113.951 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.91 160.51 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.367 1.867 . . . . 1.0 113.363 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.48 -175.06 4.49 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.937 1.695 . . . . 1.0 109.75 169.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.13 -27.23 66.89 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 120.271 -1.518 . . . . 1.0 114.446 -171.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -82.08 -15.35 53.81 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.42 1.267 . . . . 1.0 114.42 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.19 -166.77 24.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.094 1.33 . . . . 1.0 112.715 -172.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -53.27 123.96 13.29 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.468 -1.019 . . . . 1.0 109.406 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.7 t -104.1 -48.85 3.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.252 1.204 . . . . 1.0 114.252 -168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -150.89 166.78 29.53 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.979 0.895 . . . . 1.0 113.298 -169.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.3 p -132.99 158.76 41.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.168 2.187 . . . . 1.0 111.378 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -151.42 158.19 43.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.293 1.037 . . . . 1.0 111.94 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.7 p -117.67 -12.02 10.34 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.818 1.647 . . . . 1.0 113.648 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.0 -12.61 60.66 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.097 1.332 . . . . 1.0 113.653 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -72.95 159.47 33.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.573 1.149 . . . . 1.0 112.426 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.85 -117.22 8.46 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 121.397 -0.814 . . . . 1.0 112.65 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.95 159.17 42.74 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.88 1.672 . . . . 1.0 111.494 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.2 m -53.58 123.71 38.47 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.964 1.706 . . . . 1.0 112.895 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.72 154.15 32.87 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.877 3.052 . . . . 1.0 114.331 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.87 74.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.3 t -72.25 -35.57 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 120.77 -1.206 . . . . 1.0 111.667 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.05 -50.56 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.128 0.571 . . . . 1.0 109.923 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -66.31 -43.14 87.06 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.733 0.642 . . . . 1.0 112.733 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -65.02 -34.31 78.13 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.722 -0.611 . . . . 1.0 112.452 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.44 -38.8 90.95 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.07 -45.97 83.08 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.268 -0.895 . . . . 1.0 111.835 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.22 -39.62 62.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.833 1.253 . . . . 1.0 114.143 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.97 -16.33 13.12 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.572 1.323 . . . . 1.0 114.572 -169.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.35 1.79 7.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.384 1.074 . . . . 1.0 113.288 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.81 70.66 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.957 1.265 . . . . 1.0 115.282 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -66.65 168.14 9.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.513 1.157 . . . . 1.0 112.899 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -128.87 161.56 29.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.069 1.748 . . . . 1.0 109.07 169.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.1 tp -62.89 -26.06 68.61 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.68 -22.11 63.56 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.92 -21.1 66.32 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.143 0.883 . . . . 1.0 112.773 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -118.48 -14.56 9.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.2 1.8 . . . . 1.0 113.496 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.19 133.33 49.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.142 2.177 . . . . 1.0 112.542 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.91 -9.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 115.818 1.784 . . . . 1.0 115.818 176.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -136.13 -76.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.955 1.465 . . . . 1.0 114.955 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -143.44 163.92 31.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.464 1.106 . . . . 1.0 112.609 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -128.22 159.55 34.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.505 1.522 . . . . 1.0 111.658 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.256 1.822 . . . . 1.0 112.691 -173.15 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.537 0.199 . . . . 1.0 111.537 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.0 168.02 24.23 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.414 1.486 . . . . 1.0 112.147 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -138.82 153.0 71.62 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 125.924 1.69 . . . . 1.0 111.297 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.34 164.16 36.66 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.155 2.57 . . . . 1.0 112.927 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.02 172.17 18.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.797 1.639 . . . . 1.0 111.536 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -137.07 -17.9 1.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.004 1.322 . . . . 1.0 114.493 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -127.8 158.82 36.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.86 1.264 . . . . 1.0 110.898 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 t -152.89 147.05 25.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.322 1.049 . . . . 1.0 111.716 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -143.45 167.52 22.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 115.48 1.659 . . . . 1.0 115.48 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.52 126.28 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 130.441 3.497 . . . . 1.0 108.269 -169.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.23 -55.21 5.94 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.363 0.529 . . . . 1.0 111.836 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -160.69 -59.83 0.06 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.864 1.266 . . . . 1.0 111.916 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -73.32 -24.49 60.38 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.92 -175.7 45.85 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.023 1.297 . . . . 1.0 112.833 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.13 137.21 22.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.023 0.929 . . . . 1.0 112.811 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.7 m -116.89 -60.46 1.84 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.803 1.241 . . . . 1.0 111.224 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -163.63 170.7 16.77 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.407 1.262 . . . . 1.0 114.407 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 p -100.03 163.42 12.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.287 1.835 . . . . 1.0 111.601 173.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -150.1 157.71 43.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.34 1.456 . . . . 1.0 111.61 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -103.78 -16.41 15.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.028 1.731 . . . . 1.0 113.724 -173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.81 -7.07 65.0 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 124.901 1.239 . . . . 1.0 113.541 -169.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -78.0 145.55 35.91 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 1.247 . . . . 1.0 111.8 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.92 -168.63 46.88 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 123.529 0.585 . . . . 1.0 113.683 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -64.89 149.32 49.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.792 0.837 . . . . 1.0 112.23 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -61.26 132.27 92.51 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.652 1.181 . . . . 1.0 111.885 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.29 142.12 29.93 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.047 3.165 . . . . 1.0 114.055 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.55 -48.47 74.68 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -169.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.52 -30.94 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.012 -1.055 . . . . 1.0 113.359 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.3 mt -62.48 -47.42 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 118.755 0.707 . . . . 1.0 109.756 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -58.62 -44.79 90.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.24 0.616 . . . . 1.0 111.724 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -66.31 -33.54 75.97 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.283 -0.886 . . . . 1.0 112.999 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.09 82.93 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 170.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 43.7 mtt -67.5 -45.56 75.45 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.42 -0.8 . . . . 1.0 112.111 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -72.77 -38.91 67.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.628 1.344 . . . . 1.0 114.628 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -111.6 -16.7 13.2 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.733 1.382 . . . . 1.0 114.733 -169.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -127.22 0.33 6.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.22 1.008 . . . . 1.0 113.17 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.34 18.02 69.05 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.701 1.143 . . . . 1.0 115.164 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -70.08 171.6 9.33 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.588 1.194 . . . . 1.0 111.539 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -127.31 164.2 22.28 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.308 1.443 . . . . 1.0 109.882 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.5 tp -61.74 -26.93 68.37 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.61 0.967 . . . . 1.0 113.61 -171.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.35 -20.61 44.95 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.224 1.194 . . . . 1.0 114.224 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.01 -14.38 62.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.334 0.865 . . . . 1.0 113.334 170.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -122.4 -17.81 6.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.755 2.022 . . . . 1.0 113.099 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -66.3 120.31 13.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.693 1.597 . . . . 1.0 110.119 171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.9 pp -124.96 -12.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 116.618 2.081 . . . . 1.0 116.618 -170.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -67.35 -51.49 51.68 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 120.423 1.465 . . . . 1.0 112.622 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -160.69 144.49 13.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.156 1.382 . . . . 1.0 110.619 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 67.9 mt -144.54 157.58 44.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.379 1.472 . . . . 1.0 111.252 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.344 1.857 . . . . 1.0 112.466 -179.147 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.64 0.257 . . . . 1.0 111.574 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.95 164.75 32.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.277 1.431 . . . . 1.0 112.107 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 79.5 mtp85 -132.06 -36.08 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 116.836 2.162 . . . . 1.0 116.836 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.478 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 72.5 Cg_exo -56.44 157.52 18.22 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.949 3.099 . . . . 1.0 114.599 176.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 161.62 19.85 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.492 0.923 . . . . 1.0 113.492 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.7 -10.61 3.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.646 1.979 . . . . 1.0 112.969 174.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -135.99 152.94 51.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.506 1.522 . . . . 1.0 111.54 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.2 t -145.58 142.75 29.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.342 1.457 . . . . 1.0 110.881 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -149.75 172.71 14.67 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.395 1.078 . . . . 1.0 113.815 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.14 155.01 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 127.341 2.256 . . . . 1.0 111.017 -169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -119.59 -44.63 2.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.199 0.999 . . . . 1.0 112.986 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -151.09 -61.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 119.301 0.955 . . . . 1.0 113.476 173.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.98 -21.98 59.8 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.988 1.477 . . . . 1.0 114.988 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.43 -177.58 30.92 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.698 1.618 . . . . 1.0 111.638 -172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -47.83 115.35 1.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.758 0.789 . . . . 1.0 110.711 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.1 t -109.14 -38.48 5.53 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.142 1.164 . . . . 1.0 114.142 -168.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -149.9 165.93 31.11 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.687 1.195 . . . . 1.0 112.254 -171.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.3 p -133.03 164.32 27.27 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.899 1.679 . . . . 1.0 111.988 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -150.89 157.61 43.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.462 1.105 . . . . 1.0 111.157 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.8 p -98.19 -17.45 18.99 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.79 1.636 . . . . 1.0 113.78 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.82 -7.46 67.75 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 124.777 1.179 . . . . 1.0 113.411 -169.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -78.75 149.24 32.72 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.593 1.196 . . . . 1.0 111.835 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.07 -170.65 37.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 123.709 0.671 . . . . 1.0 114.076 -177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -62.19 151.2 36.72 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.69 0.796 . . . . 1.0 112.737 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 51.9 m -56.81 127.77 74.98 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.951 1.3 . . . . 1.0 111.423 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 147.25 59.84 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.663 2.908 . . . . 1.0 113.294 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.28 -45.49 80.12 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.929 1.085 . . . . 1.0 113.929 -170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.67 -35.42 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.996 -1.065 . . . . 1.0 112.87 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.3 mm -66.09 -45.26 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.939 0.896 . . . . 1.0 109.963 174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -58.22 -46.51 85.76 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.056 0.942 . . . . 1.0 111.844 173.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -62.1 -38.58 89.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.383 0.673 . . . . 1.0 112.106 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.11 89.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.835 0.68 . . . . 1.0 112.835 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 46.1 mtt -64.02 -45.25 89.78 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.353 -0.842 . . . . 1.0 112.171 172.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -75.36 -36.98 60.88 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.801 1.408 . . . . 1.0 114.801 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -111.7 -14.84 13.55 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.797 1.406 . . . . 1.0 114.797 -169.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -124.68 -0.36 8.05 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.572 1.149 . . . . 1.0 113.169 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.11 14.79 64.29 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 124.582 1.087 . . . . 1.0 114.96 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -68.69 170.82 8.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.315 1.058 . . . . 1.0 112.662 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -134.98 176.5 8.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.081 1.752 . . . . 1.0 110.241 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.22 -40.34 70.71 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.093 -1.004 . . . . 1.0 112.451 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -64.87 -19.24 65.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.16 -24.15 67.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.255 0.934 . . . . 1.0 112.758 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -122.51 -13.32 8.02 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.341 1.456 . . . . 1.0 113.331 -174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.72 131.94 41.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.826 2.05 . . . . 1.0 111.121 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.3 pt -127.22 -8.43 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.623 2.083 . . . . 1.0 116.623 -171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -130.03 18.52 5.53 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.208 1.929 . . . . 1.0 116.208 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -142.63 16.32 1.99 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.9 mt -129.79 23.87 5.37 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.85 1.26 . . . . 1.0 112.957 -169.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.928 1.691 . . . . 1.0 113.656 174.744 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 111.874 0.324 . . . . 1.0 111.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.93 28.3 8.38 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 116.587 2.069 . . . . 1.0 116.587 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -136.99 62.32 39.19 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 125.946 1.698 . . . . 1.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -68.97 163.46 37.53 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.649 2.899 . . . . 1.0 113.288 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 171.92 15.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.575 1.55 . . . . 1.0 112.049 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -141.26 -19.56 0.78 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.67 1.588 . . . . 1.0 114.017 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.71 159.78 41.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.178 . . . . 1.0 110.501 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.7 p -151.77 156.66 40.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.991 0.916 . . . . 1.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -146.36 172.36 13.61 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 114.401 1.26 . . . . 1.0 114.401 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.0 t -137.09 125.44 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.869 2.068 . . . . 1.0 109.752 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.13 -52.07 7.77 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.861 0.864 . . . . 1.0 112.13 173.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -161.04 -45.95 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.069 1.137 . . . . 1.0 114.069 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -64.21 -25.5 68.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 1.0 116.521 -169.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 139.44 -39.6 1.52 Allowed Glycine 0 N--CA 1.478 1.454 0 C-N-CA 124.531 1.062 . . . . 1.0 113.878 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -144.12 133.75 23.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.606 1.962 . . . . 1.0 109.489 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.6 m -117.28 -71.24 0.75 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 117.94 -1.029 . . . . 1.0 112.474 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -160.06 177.06 11.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -114.42 163.59 15.13 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.031 2.133 . . . . 1.0 112.385 -177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -148.43 158.44 44.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.082 1.753 . . . . 1.0 110.636 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -120.89 0.66 10.33 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.47 32.31 11.98 Favored Glycine 0 N--CA 1.474 1.224 0 O-C-N 121.064 -1.022 . . . . 1.0 114.33 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -136.27 160.67 38.0 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.72 1.608 . . . . 1.0 111.386 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.45 -106.75 2.06 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 123.745 0.688 . . . . 1.0 111.518 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.74 151.64 48.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.573 1.549 . . . . 1.0 111.353 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.8 m -57.82 127.11 78.38 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.717 1.207 . . . . 1.0 111.55 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.72 145.6 38.45 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 3.136 . . . . 1.0 114.062 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.72 76.9 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.049 1.129 . . . . 1.0 114.049 -171.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.12 -41.88 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.496 -0.752 . . . . 1.0 111.418 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.67 -44.61 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.712 0.805 . . . . 1.0 110.163 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -58.69 -49.85 76.04 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 1.0 111.281 174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -62.46 -37.54 86.32 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.59 -37.73 88.45 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 51.1 mtt -67.64 -47.46 69.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.522 -0.736 . . . . 1.0 112.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -73.99 -42.45 60.39 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.316 1.228 . . . . 1.0 114.316 -173.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.74 -14.55 12.56 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.644 1.349 . . . . 1.0 114.644 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -120.31 -0.37 10.43 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.274 1.03 . . . . 1.0 113.426 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.91 17.29 69.38 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.977 1.275 . . . . 1.0 115.488 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -71.53 170.66 12.87 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.541 1.171 . . . . 1.0 112.395 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.31 163.3 21.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.805 1.642 . . . . 1.0 109.659 172.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 27.6 tp -63.39 -25.06 68.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.952 0.901 . . . . 1.0 113.314 -172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.48 -24.5 63.65 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.149 0.98 . . . . 1.0 113.153 172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.13 -16.4 63.45 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.12 -0.987 . . . . 1.0 113.453 171.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -120.4 -16.04 8.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.697 1.999 . . . . 1.0 113.157 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.53 138.16 41.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.871 2.068 . . . . 1.0 112.194 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.87 -21.93 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 116.047 1.869 . . . . 1.0 116.047 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -137.43 -55.36 0.69 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 117.177 2.288 . . . . 1.0 117.177 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -164.9 140.66 5.58 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.806 1.185 . . . . 1.0 111.914 -173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.33 16.93 2.4 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.507 1.299 . . . . 1.0 114.507 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 126.26 1.824 . . . . 1.0 111.967 -178.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.761 0.282 . . . . 1.0 111.761 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -147.63 169.47 19.57 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.214 1.406 . . . . 1.0 112.131 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.55 149.65 94.99 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.504 1.122 . . . . 1.0 112.752 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -83.83 31.86 0.51 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 124.923 3.749 . . . . 1.0 113.431 175.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.53 170.59 21.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.735 2.014 . . . . 1.0 110.921 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -121.69 -14.43 8.15 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.3 1.222 . . . . 1.0 114.3 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -131.46 157.37 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.262 1.425 . . . . 1.0 110.807 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 80.5 p -146.75 159.99 42.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.024 0.93 . . . . 1.0 112.595 171.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -142.64 165.04 28.48 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.816 0.847 . . . . 1.0 113.161 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.51 142.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.829 2.052 . . . . 1.0 110.651 -169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -145.79 -42.07 0.21 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.94 1.296 . . . . 1.0 111.529 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -76.89 -159.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.164 1.786 . . . . 1.0 111.393 172.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -63.48 -1.9 1.37 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.608 1.963 . . . . 1.0 115.384 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.06 -160.19 23.59 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 126.254 1.883 . . . . 1.0 111.193 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -50.97 130.37 25.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.528 0.731 . . . . 1.0 111.815 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.6 m -113.83 -52.23 2.75 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.646 1.579 . . . . 1.0 111.37 -169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -147.18 168.92 20.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.739 1.216 . . . . 1.0 112.207 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.3 p -128.26 159.74 34.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.99 1.716 . . . . 1.0 112.401 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -151.04 159.62 44.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.799 1.24 . . . . 1.0 112.182 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.7 p -111.16 -4.39 15.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.999 1.72 . . . . 1.0 114.211 -169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.25 20.72 58.41 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.74 0.686 . . . . 1.0 114.229 -175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -132.8 163.9 28.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.359 1.464 . . . . 1.0 112.276 -171.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 -94.37 0.83 Allowed Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.658 1.123 . . . . 1.0 112.145 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -142.32 147.73 36.82 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.941 1.696 . . . . 1.0 111.161 172.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 m -60.04 129.75 88.48 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.632 1.173 . . . . 1.0 111.723 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.51 142.45 30.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.125 3.217 . . . . 1.0 114.035 173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.95 77.31 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.691 0.997 . . . . 1.0 113.691 -170.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.01 -34.72 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 O-C-N 121.075 -1.015 . . . . 1.0 112.599 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.3 mt -65.2 -47.23 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.308 0.643 . . . . 1.0 109.755 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.67 -49.03 76.27 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.027 0.931 . . . . 1.0 111.348 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.08 -36.91 85.54 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.714 -0.616 . . . . 1.0 112.441 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.39 83.26 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.066 0.765 . . . . 1.0 113.066 172.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.3 mtp -63.89 -43.73 95.15 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.083 -1.011 . . . . 1.0 111.803 171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.75 -41.68 59.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.298 1.222 . . . . 1.0 114.298 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -111.97 -15.55 13.28 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.0 1.482 . . . . 1.0 115.0 -171.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -121.32 3.98 10.28 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.405 1.082 . . . . 1.0 113.112 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.91 15.33 69.11 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.077 1.322 . . . . 1.0 115.371 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -68.33 169.61 10.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.426 1.113 . . . . 1.0 113.061 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -130.76 168.84 16.55 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.403 1.881 . . . . 1.0 109.461 170.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.0 -30.3 70.21 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.739 -1.226 . . . . 1.0 112.794 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.75 -21.94 66.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.178 1.177 . . . . 1.0 114.178 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -66.32 -14.01 61.39 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.647 1.112 . . . . 1.0 113.275 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -122.29 -11.64 8.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.497 1.919 . . . . 1.0 112.994 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.66 122.18 20.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 1.0 109.982 173.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.3 -14.8 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 117.459 2.392 . . . . 1.0 117.459 -169.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -92.29 -22.93 19.47 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 120.738 1.608 . . . . 1.0 114.681 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -124.22 13.78 8.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.093 0.957 . . . . 1.0 113.499 -170.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.94 160.92 37.46 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.688 1.595 . . . . 1.0 111.693 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.112 1.765 . . . . 1.0 112.2 179.948 . . . . . . . . 0 0 . 1 stop_ save_